Delaware | 83-4364296 | ||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) | ||
Large accelerated filer | ☒ | Accelerated filer | ☐ | ||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||
Emerging growth company | ☐ | ||||||||
Exact name of additional registrant guarantor as specified in its charter | State or other jurisdiction of incorporation or organization | I.R.S. Employer Identification Number | Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices | Name, address, including zip code, and telephone number, including area code, of agent for service | ||||||||
Mylan Inc. | Pennsylvania | 25-1211621 | 1000 Mylan Boulevard Canonsburg, Pennsylvania 15317 | c/o CT Corporation System, Washington County | ||||||||
Mylan II B.V. | Netherlands | N/A | Krijgsman 20 1186 DM Amstelveen Amsterdam, the Netherlands | Corporation Service Company 19 West 44th Street, Suite 200, New York, NY 10036 | ||||||||
Utah Acquisition Sub Inc. | Delaware | 84-4554869 | 1000 Mylan Boulevard Canonsburg, Pennsylvania 15317 | The Corporation Trust Company Corporation Trust Center 1209 Orange Street Wilmington, DE 19801 |

• | should not in any instance be treated as categorical statements of fact, but rather as a way of allocating the risk among the parties to such documents if those statements prove to be inaccurate; |
• | may be qualified by disclosures that were made to the other party in connection with the negotiation of the applicable document, which disclosures are not necessarily reflected in the document; |
• | may apply standards of materiality in ways that are different from what may be viewed as material to you or other investors; and |
• | were made only as of the date of the applicable document or such other date or dates as may be specified in the document and are subject to more recent developments. |
• | Annual Report on Form 10-K of Viatris for the year ended December 31, 2024, filed on February 27, 2025, as amended by Amendment No. 1 on Form 10-K/A, filed on April 30, 2025; |
• | Quarterly Report on Form 10-Q of Viatris for the quarter ended March 31, 2025, filed on May 8, 2025; |
• | Current Reports on Form 8-K of Viatris, filed on February 27, 2025 (Item 8.01 only), May 5, 2025 (Item 5.02 only) and May 8, 2025 (Item 8.01 only); and |
• | the description of our capital stock contained in Exhibit 4.9 to the Annual Report on Form 10-K of Viatris for the year ended December 31, 2023, filed on February 28, 2024, as supplemented by any subsequent amendments and reports filed for the purpose of updating such description. |
• | the possibility that the Company may not realize the intended benefits of, or achieve the intended goals or outlooks with respect to its strategic initiatives and priorities (including divestitures, acquisitions, strategic alliances, collaborations or other potential transactions) or accelerate its growth by building on the strength of its base business with an expanding portfolio of innovative, best-in-class, patent-protected assets; |
• | the possibility that the Company may be unable to achieve intended or expected benefits, goals, outlooks, synergies, growth opportunities and operating efficiencies in connection with divestitures, acquisitions, strategic alliances, collaborations or other transactions or restructuring programs, within the expected timeframes or at all; |
• | the ongoing risks and uncertainties associated with our recent divestitures; |
• | goodwill or impairment charges or other losses; |
• | the Company’s failure to achieve expected or targeted future financial and operating performance and results; |
• | the potential impact of natural or man-made disasters, public health outbreaks, epidemics, pandemics or social disruption in regions where we or our partners or suppliers operate; |
• | actions and decisions of healthcare and pharmaceutical regulators; |
• | changes in relevant laws, regulations and policies and/or the application or implementation thereof, including but not limited to tax, healthcare and pharmaceutical laws, regulations and policies globally; |
• | the ability to attract, motivate and retain key personnel; |
• | the Company’s liquidity, capital resources and ability to obtain financing; |
• | any regulatory, legal or other impediments to the Company’s ability to bring new products to market, including but not limited to “at-risk launches”; |
• | products in development that receive regulatory approval may not achieve expected levels of market acceptance, efficacy or safety; |
• | longer review, response and approval times as a result of evolving regulatory priorities and reductions in personnel at health agencies; |
• | success of clinical trials and the Company’s or its partners’ ability to execute on new product opportunities and develop, manufacture and commercialize products; |
• | any changes in or difficulties with the Company’s manufacturing facilities, including with respect to inspections, remediation and restructuring activities, supply chain or inventory or the ability to meet anticipated demand; |
• | the scope, timing and outcome of any ongoing legal proceedings, including government inquiries or investigations, and the impact of any such proceedings on the Company; |
• | any significant breach of data security or data privacy or disruptions to our IT systems; |
• | risks associated with having significant operations globally; |
• | the ability to protect intellectual property and preserve intellectual property rights; |
• | changes in third-party relationships; |
• | the effect of any changes in the Company’s or its partners’ customer and supplier relationships and customer purchasing patterns, including customer loss and business disruption being greater than expected following an adverse regulatory action, acquisition or divestiture; |
• | the impacts of competition, including decreases in sales or revenues as a result of the loss of market exclusivity for certain products; |
• | changes in the economic and financial conditions of the Company or its partners; |
• | uncertainties regarding future demand, pricing and reimbursement for the Company’s products; |
• | uncertainties and matters beyond the control of management, including but not limited to general political and economic conditions, potential for adverse impacts from future tariffs and trade restrictions, inflation rates and global exchange rates; and |
• | inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements, and the providing of estimates of financial measures, in accordance with U.S. GAAP and related standards or on an adjusted basis. |
• | title, aggregate principal amount and, if a series, the total principal amount authorized and the total principal amount outstanding; |
• | whether the securities are senior, subordinated or junior subordinated debt securities; |
• | provisions relating to conversion or exchange of debt securities into any securities or property; |
• | percentage(s) of principal amount at which such securities will be issued, including any original issue discount; |
• | issuance date; |
• | maturity date(s); |
• | interest rate(s), which may be fixed rate or variable rate, or the method for determining the interest rate(s); |
• | date(s) on which interest will accrue or the method for determining dates on which interest will accrue, the date(s) on which interest will be payable, the record date(s) for such interest payment date(s) and the basis on which interest will be calculated; |
• | whether interest will be payable in cash or in additional debt securities of the same series, or shall accrue and increase the aggregate principal amount outstanding of such series (including if the debt securities were originally issued at a discount); |
• | the identities of guarantors, if any, and the terms on which the payment of interest, premium (if any) and principal on the debt securities will be guaranteed by such guarantors; |
• | whether, and under which circumstances, if any, additional amounts on the debt securities will be payable and whether, and the terms on which, debt securities will be redeemable if such additional amounts are payable; |
• | mandatory or optional redemption or early repayment provisions; |
• | authorized dollar amounts of denominations; |
• | form; |
• | amount of discount or premium, if any, with which such securities will be issued; |
• | whether such securities will be issued in whole or in part in the form of one or more global securities and, if so, the identity of the depositary or depositaries for global securities; |
• | whether a temporary security is to be issued with respect to such series and whether any interest payable prior to the issuance of definitive securities of the series will be credited to the account of the persons entitled thereto; |
• | the terms upon which beneficial interests in a temporary global security may be exchanged in whole or in part for beneficial interests in a definitive global security or for individual definitive securities; |
• | any covenants applicable to the particular debt securities being issued; |
• | any defaults and events of default applicable to the particular debt securities being issued; |
• | currency, currencies or currency units in which the debt securities are denominated and in which the purchase price for, the principal of and any premium and any interest on such securities will be payable; |
• | securities exchange(s) on which the securities will be listed, if any; |
• | our obligation or right to redeem, purchase or repay securities under a sinking fund, amortization or analogous provision; |
• | provisions relating to covenant defeasance and legal defeasance; |
• | provisions relating to satisfaction and discharge of the applicable indenture; |
• | provisions relating to the modification of the applicable indenture both with and without the consent of holders of debt securities issued under such indenture; |
• | provisions, if any, granting special rights upon the occurrence of specified events; |
• | any restriction of transferability, sale or assignment of the series; |
• | whether the debt securities of a series will be secured by any collateral and, if so, the terms and conditions upon which such debt securities shall be secured and, if applicable, upon which such liens may be subordinated to other liens securing other indebtedness; and |
• | additional terms subject to the applicable provisions of the applicable indenture. |
• | any aspect of the records relating to or payments made by the depositary, its nominee or any participants on account of beneficial interests in the global security or for maintaining, supervising or reviewing any records relating to such beneficial interests; |
• | the payment to the owners of beneficial interests in the global security of amounts paid to the depositary or its nominee; or |
• | any other matter relating to the actions and practices of the depositary, its nominee or its participants. |
(1) | either the Company shall be the continuing entity or the successor, transferee or lessee entity, if other than the Company (the “Successor Company”), shall expressly assume, by a supplemental indenture, executed and delivered to the trustee, all the obligations of the Company under the debt securities and the indenture; |
(2) | immediately after such transaction, no default shall have occurred and be continuing; and |
(3) | the Company shall have delivered to the trustee an officer’s certificate and an opinion of counsel, each stating that such consolidation, merger, sale or lease and such supplemental indenture comply with the indenture. |
(1) | a failure to pay interest on the debt securities of such series that continues for a period of 30 days after payment is due; provided that if we are permitted by the terms of the debt securities to defer the payment in question, the date on which such payment is due and payable shall be the date on which we must make payment following such deferral, if the deferral has been made pursuant to the terms of the debt securities of that series; |
(2) | a failure to pay the principal or premium, if any, on the debt securities of such series when due upon maturity, redemption (otherwise than pursuant to a sinking fund), acceleration or otherwise; provided that if we are permitted by the terms of the debt securities to defer the payment in question, the date on which such payment is due and payable shall be the date on which we must make payment following such deferral, if the deferral has been made pursuant to the terms of the debt securities of that series; |
(3) | a failure to comply with the covenant described above under the caption “—Consolidation, Merger and Sale of Assets”; |
(4) | a failure to comply with (x) any of the Company’s and the guarantors’ other applicable agreements contained in the applicable indenture and applicable to the debt securities of such series (other than (i) a failure that is subject to the foregoing clause (1), (2) or (3) or (ii) a failure to comply with the covenant described above under the caption “—Reports”) for a period of 60 days after receipt by the Company of written notice of such failure from the trustee for the debt securities of such series (or receipt by the Company and the trustee of written notice of such failure from the holders of at least 25% of the principal amount of the applicable series of debt securities) or (y) the requirements set forth in the covenant described above under the caption “—Reports” for a period of 120 days after receipt by the Company of written notice of such failure from the trustee for the debt securities of such series (or receipt by the Company and the trustee of written notice of such failure from the holders of at least 25% of the principal amount of the applicable series of debt securities); |
(5) | with respect to senior debt securities, one or more defaults shall have occurred under any of the agreements, indentures or instruments under which the Company or any significant subsidiary of the Company has outstanding indebtedness in excess of $250.0 million, individually or in the aggregate, and either (a) such default results from the failure to pay such indebtedness at its stated final maturity and such default has not been cured or the indebtedness repaid in full within 20 days of the default or (b) such default or defaults have resulted in the acceleration of the maturity of such indebtedness and such acceleration has not been rescinded or such indebtedness repaid in full within 20 days of the acceleration; |
(6) | with respect to senior debt securities, one or more judgments or orders that exceed $250.0 million in the aggregate (net of amounts covered by insurance or bonded) for the payment of money have been entered by a court or courts of competent jurisdiction against the Company or any significant subsidiary of the Company and such judgment or judgments have not been satisfied, stayed, annulled or rescinded within 60 days after such judgment or judgments become final and nonappealable; |
(7) | any guarantee by a significant subsidiary of the Company of the Company’s Indenture Obligations (as defined in the applicable indenture) under such series of debt securities shall for any reason cease to be, or shall for any reason be held in any judicial proceeding not to be, or asserted in writing by any significant subsidiary of the Company or the Company not to be, in full force and effect and enforceable in accordance with its terms, except to the extent contemplated by the applicable indenture and any such guarantee by such significant subsidiary of the Company’s Indenture Obligations under such series of debt securities, and any such default continues for 10 days; |
(8) | certain events of bankruptcy, insolvency or reorganization relating to the Company or any of its significant subsidiaries; |
(9) | the failure of the Company to pay a sinking fund installment, if any, when and as the same shall become payable by the terms of a debt security of such series, which failure shall have continued unremedied for a period of 30 days; and |
(10) | the occurrence of any other event of default with respect to debt securities of such series as described in the applicable prospectus supplement or free writing prospectus. |
• | the trustee has failed to institute such proceeding for 60 days after the holder has previously given to the trustee written notice of a continuing event of default with respect to the debt securities of such series; |
• | the holders of at least 25% in aggregate principal amount of the outstanding debt securities of such series have made a written request, and offered to the trustee reasonable security and/or indemnity satisfactory to it to institute such proceeding as trustee; and |
• | the trustee has not received from the holders of a majority in aggregate principal amount of the outstanding debt securities of such series a direction that is inconsistent with such request. |
• | cure any ambiguity, defect, mistake or inconsistency in the applicable indenture; |
• | provide for uncertificated debt securities in addition to or in place of certificated debt securities; |
• | comply with the provisions described above under the caption “—Consolidation, Merger and Sale of Assets” or the covenant in the applicable indenture governing guarantees, including to provide for or evidence the release of any guarantor in accordance with the terms thereof; |
• | evidence and provide for the acceptance of appointment by a successor trustee and add to or change any provisions of the indenture as shall be necessary for or facilitate the administration of the trusts thereunder by more than one trustee, pursuant to the requirements of the applicable indenture; |
• | comply with requirements of the SEC in order to effect or maintain the qualification of the applicable indenture or any supplemental indenture thereto under the Trust Indenture Act; |
• | make any change that would provide any additional rights or benefits to the holders of the debt securities of such series or that does not adversely affect in any material respect the legal rights under the applicable indenture of the holders of the debt securities of such series; |
• | secure any series of debt securities; |
• | establish the form and terms of securities of any series pursuant to the applicable indenture, or authorize the issuance of additional debt securities of a series previously authorized; |
• | add covenants for the benefit of the holders of such series of debt securities or to surrender any right or power conferred upon the Company or any guarantor; |
• | conform the text of the applicable indenture, any supplemental indenture thereto, the debt securities or any guarantees thereof to the extent a provision thereof was intended to be a substantially verbatim recitation of the applicable provision of the “Description of Debt Securities and Guarantees” or the “Description of Notes and Guarantees” (or comparable section) contained in the applicable registration statement, prospectus, prospectus supplement, free-writing prospectus or offering memorandum; |
• | allow any guarantor to execute a supplemental indenture and/or guarantee with respect to the debt securities of any series; |
• | add to, change or eliminate any of the provisions of the applicable indenture with respect to one or more series of debt securities, so long as any such addition, change or elimination not otherwise permitted under the indenture shall (A) neither apply to any debt security of any series created under such indenture prior to the execution of such supplemental indenture and entitled to the benefit of such provision nor modify the rights of the holders of any such debt security with respect to the benefit of such provision or (B) become effective only when there is no such debt security outstanding; |
• | supplement any of the provisions of the applicable indenture to such extent as shall be necessary to permit or facilitate the defeasance and discharge of any series of debt securities; provided that any such action shall not adversely affect the interests of the holders of debt securities of such series or any other series of debt securities; |
• | prohibit the authentication and delivery of additional series of debt securities; |
• | solely with respect to the subordinated debt indenture, to make any change to the applicable provisions of such indenture that limit or terminate the benefits applicable to any holder of senior debt securities; and |
• | solely with respect to the junior subordinated debt indenture, to make any changes to the applicable provisions of such indenture that limit or terminate the benefits applicable to any holder of senior debt securities or subordinated debt securities. |
• | extend the due date of the principal of, or any installment of principal of or interest on, the debt securities of such series, or reduce the amount of the principal of an original issue discount security; |
• | materially adversely affect the economic terms of a right to convert or exchange any debt security of such series, if any; |
• | reduce the principal amount of, or any premium or interest rate on, the debt securities of such series; |
• | change the place or currency of payment of principal of, or any premium or interest on, the debt securities of such series; |
• | reduce the amount payable upon the redemption of any debt security of such series; |
• | impair the right to institute suit for the enforcement of any payment on or with respect to the debt securities of such series after the due date thereof; or |
• | reduce the percentage in principal amount of the debt securities of such series then outstanding, the consent of whose holders is required for modification or amendment of the indenture, for waiver of compliance with certain provisions of the indenture or for waiver of certain defaults. |
• | either the delivery to the trustee for cancellation all debt securities of such series or, in the case of a series of debt securities that have become due and payable, will become due and payable within one year or have been called for redemption, the irrevocable deposit with the trustee in trust of cash, government obligations or a combination thereof sufficient to pay off the entire indebtedness on the debt securities of such series; |
• | we or any guarantor has paid all sums payable by it with respect to such series of debt securities under the applicable indenture; and |
• | we have delivered irrevocable instructions to the trustee for such series of debt securities under the applicable indenture to apply the deposited money toward the payment of the debt securities at maturity or on the redemption date, as the case may be. |
• | deemed to have paid and discharged the entire indebtedness of the debt securities of such series and any guarantees thereof (a “legal defeasance option”); or |
• | released from our obligations and any of our guarantor’s obligations under certain restrictive covenants in the indenture and, following such release, noncompliance with such covenants shall not constitute a default or an event of default (a “covenant defeasance option”). |
• | of any insolvency, bankruptcy, receivership, liquidation, reorganization or other similar proceedings in respect of us or our property; or |
• | that debt securities of any series are declared due and payable before their expressed maturity because of an event of default other than an insolvency, bankruptcy, receivership, liquidation, reorganization or other similar proceeding in respect of us or our property. |
• | of any insolvency, bankruptcy, receivership, liquidation, reorganization or other similar proceedings in respect of us or our property; or |
• | that debt securities of any series are declared due and payable before their expressed maturity because of an event of default other than an insolvency, bankruptcy, receivership, liquidation, reorganization or other similar proceeding in respect of us or our property. |
• | the board of directors approved the acquisition of stock pursuant to which the person became an interested stockholder or the transaction that resulted in the person becoming an interested stockholder before the time that the person became an interested stockholder; |
• | upon consummation of the transaction that resulted in the person becoming an interested stockholder such person owned at least 85% of the outstanding voting stock of the corporation, excluding, for purposes of determining the voting stock outstanding, voting stock owned by directors who are also officers and certain employee stock plans; or |
• | the transaction is approved by the board of directors and by the affirmative vote of two-thirds of the outstanding voting stock which is not owned by the interested stockholder. |
• | the title of the debt warrants; |
• | the aggregate number of the debt warrants outstanding, if any; |
• | the number of debt warrants being offered; |
• | the price or prices at which the debt warrants will be issued; |
• | the designation, aggregate principal amount and terms of the debt securities purchasable upon exercise of the debt warrants, and the procedures and conditions relating to the exercise of the debt warrants; |
• | the designation and terms of any related debt securities with which the debt warrants are issued, and the number of the debt warrants issued with each security; |
• | the date, if any, on and after which the debt warrants and the related securities will be separately transferable; |
• | the principal amount of debt securities purchasable upon exercise of each debt warrant, and the price at which the debt securities may be purchased upon exercise; |
• | the provisions, if any, for changes to or adjustments in the exercise price; |
• | the date on which the right to exercise the debt warrants shall commence and the date on which such right shall expire; |
• | the terms, if any, on which we may accelerate the date by which the debt warrants must be exercised; |
• | the minimum or maximum amount of debt warrants that may be exercised at any one time; |
• | the currency for which the debt warrants may be purchased; |
• | information with respect to book-entry procedures, if any; |
• | the redemption or call provisions of such warrants, if any; |
• | a discussion of material U.S. federal and, if applicable, Dutch income tax considerations applicable to an investment in the debt warrants; and |
• | any other terms of the debt warrants, including terms, procedures and limitations relating to the transferability, exercise and exchange of such warrants. |
• | the title of the equity warrants; |
• | the aggregate number of the equity warrants outstanding, if any; |
• | the number of equity warrants being offered; |
• | the price or prices at which the equity warrants will be issued; |
• | the type and number of securities purchasable upon exercise of the equity warrants; |
• | the date, if any, on and after which the equity warrants and the related securities will be separately transferable; |
• | the price at which each security purchasable upon exercise of the equity warrants may be purchased; |
• | the provisions, if any, for changes to or adjustments in the exercise price; |
• | the date on which the right to exercise the equity warrants shall commence and the date on which such right shall expire; |
• | whether the equity warrants or related securities will be listed on any securities exchange; |
• | the currency for which the equity warrants may be purchased; |
• | the terms, if any, on which we may accelerate the date by which the equity warrants must be exercised; |
• | the minimum or maximum amount of equity warrants that may be exercised at any one time; |
• | information with respect to book-entry procedures, if any; |
• | any anti-dilution protection; |
• | the redemption or call provisions of such warrants, if any; |
• | a discussion of material U.S. federal income tax considerations applicable to an investment in the equity warrants; and |
• | any other terms of the equity warrants, including terms, procedures and limitations relating to the transferability, exercise and exchange of such warrants. |
• | the date of determining the persons entitled to participate in the rights distribution; |
• | the aggregate number of shares of the underlying securities purchasable upon exercise of the rights; |
• | the exercise price; |
• | the provisions, if any, for changes to or adjustments in the exercise price; |
• | the aggregate number of rights issued; |
• | the date, if any, on and after which the rights will be separately transferable; |
• | the date on which the right to exercise the rights will commence, and the date on which the rights will expire; |
• | a discussion of material U.S. federal and, if applicable, Dutch income tax considerations applicable to an investment in the rights; and |
• | any other terms of the rights, including terms, procedures and limitations relating to the distribution, exchange and exercise of the rights. |
• | the title of any series of units; |
• | identification and description of the separate constituent securities comprising the units; |
• | the price or prices at which the units will be issued; |
• | the date, if any, on and after which the constituent securities comprising the units will be separately transferable; |
• | information with respect to any book-entry procedures; |
• | a discussion of material U.S. federal and, if applicable, Dutch income tax considerations applicable to an investment in the units; |
• | whether we will apply to have the units traded on a securities exchange or securities quotation system; and |
• | any other terms of the units and their constituent securities. |
• | to or through one or more underwriters or dealers; |
• | in short or long transactions; |
• | directly by us or any selling securityholder to investors; |
• | through agents; |
• | through a combination of these methods; or |
• | through any other method permitted pursuant to applicable law. |
• | in privately negotiated transactions; |
• | in one or more transactions at a fixed price or prices, which may be changed from time to time; |
• | in one or more transactions, including “forward” transactions at a floating price or prices that may be changed from time to time; |
• | in “at-the-market offerings,” within the meaning of Rule 415(a)(4) of the Securities Act, to or through a market maker or into an existing trading market, on an exchange or otherwise; |
• | at prices related to those prevailing market prices; or |
• | at negotiated prices. |
• | the names of any underwriters, dealers, agents or other counterparties; |
• | any agency fees or underwriting discounts or commissions and other items constituting agents’ or underwriters’ compensation; |
• | any discounts or concessions allowed or reallowed or paid to dealers; |
• | details regarding over-allotment options under which underwriters may purchase additional securities from us or any selling securityholder, if any; |
• | the purchase price of the securities being offered and the proceeds we or any selling securityholder will receive from the sale; |
• | the public offering price; and |
• | the securities exchanges on which such securities may be listed, if any. |
Item 14. | Other Expenses of Issuance and Distribution |
Amount to be Paid | |||
SEC registration fee | $ * | ||
Legal fees and expenses | ** | ||
Rating agency fees | ** | ||
Accounting fees and expenses | ** | ||
Transfer agent and registrar fees and expenses | ** | ||
Trustee fees and expenses | ** | ||
Stock exchange listing fees | ** | ||
Printing costs | ** | ||
Miscellaneous | ** | ||
Total | $** | ||
* | Under Rules 456(b) and 457(r) of the Securities Act of 1933, as amended (the “Securities Act”), applicable U.S. Securities and Exchange Commission (the “SEC”) registration fees have been deferred and will be paid at the time of any particular offering of securities under this registration statement, and are therefore not estimable at this time. |
** | Because an indeterminate amount of securities is covered by this registration statement, the expenses in connection with the issuance and distribution of the securities are not currently determinable. An estimate of the aggregate amount of these expenses will be reflected in the applicable prospectus supplement or free writing prospectus. |
Item 15. | Indemnification of Directors and Officers |
Item 16. | Exhibits |
Exhibit No. | Description | ||
1.1* | Form of Underwriting Agreement. | ||
Amended and Restated Certificate of Incorporation of Upjohn Inc., effective as of November 13, 2020, filed as Exhibit 3.1 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. | |||
Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Upjohn Inc., effective as of November 16, 2020, filed as Exhibit 3.3 to the Report on Form 8-K filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. | |||
Certificate of Amendment of Amended and Restated Certificate of Incorporation of Viatris Inc., effective as of December 15, 2023, filed by Viatris Inc. as Exhibit 3.1(c) to Form 10-K for the fiscal year ended December 31, 2023, and incorporated herein by reference. | |||
Certificate of Amendment of Amended and Restated Certificate of Incorporation of Viatris Inc., effective as of December 15, 2023, filed by Viatris Inc. as Exhibit 3.1(d) to Form 10-K for the fiscal year ended December 31, 2023, and incorporated herein by reference. | |||
Amended and Restated Bylaws of Viatris Inc., effective as of December 15, 2023, filed as Exhibit 3.1 to the Report on Form 8-K filed by Viatris Inc. with the SEC on December 15, 2023, and incorporated herein by reference. | |||
Certificate of Incorporation of Utah Acquisition Sub Inc., filed as Exhibit 3.4 to the Registration Statement on Form S-4 filed by Viatris Inc. with the SEC on September 10, 2021, and incorporated herein by reference. | |||
Bylaws of Utah Acquisition Sub Inc., filed as Exhibit 3.5 to the Registration Statement on Form S-4 filed by Viatris Inc. with the SEC on September 10, 2021, and incorporated herein by reference. | |||
Deed of Incorporation of Mylan II B.V., filed as Exhibit 3.6 to the Registration Statement on Form S-4 filed by Viatris Inc. with the SEC on September 10, 2021, and incorporated herein by reference. | |||
Amended and Restated Articles of Incorporation, as Amended, of Mylan Inc., filed as Exhibit 3.7 to the Registration Statement on Form S-4 filed by Viatris Inc. with the SEC on September 10, 2021, and incorporated herein by reference. | |||
Third Amended and Restated Bylaws, as Amended, of Mylan Inc., filed as Exhibit 3.8 to the Registration Statement on Form S-4 filed by Viatris Inc. with the SEC on September 10, 2021, and incorporated herein by reference. | |||
4.11** | Form of Senior Indenture among Viatris Inc., as issuer, the guarantors party thereto and The Bank of New York Mellon, as trustee (the “Form of Viatris Inc. Senior Indenture”). | ||
4.12** | Form of Subordinated Indenture among Viatris Inc., as issuer, the guarantors party thereto and The Bank of New York Mellon, as trustee (the “Form of Viatris Inc. Subordinated Indenture”). | ||
4.13** | Form of Junior Subordinated Indenture among Viatris Inc., as issuer, the guarantors party thereto and The Bank of New York Mellon, as trustee (the “Form of Viatris Inc. Junior Subordinated Indenture”). | ||
Exhibit No. | Description | ||
Indenture, dated November 29, 2013, between Mylan Inc. and The Bank of New York Mellon, as trustee, filed as Exhibit 4.1 to the Report on Form 8-K filed by Mylan Inc. with the SEC on November 29, 2013, and incorporated herein by reference. | |||
First Supplemental Indenture, dated November 29, 2013, between Mylan Inc. and The Bank of New York Mellon, as trustee, filed as Exhibit 4.2 to the Report on Form 8-K filed by Mylan Inc. with the SEC on November 29, 2013, and incorporated herein by reference. | |||
Second Supplemental Indenture, dated February 27, 2015, among Mylan Inc., as issuer, Mylan N.V., as guarantor, and The Bank of New York Mellon, as trustee, to the Indenture, dated November 29, 2013, filed as Exhibit 4.6 to the Report on Form 8-K filed by Mylan N.V. with the SEC on February 27, 2015, and incorporated herein by reference. | |||
Third Supplemental Indenture, dated March 12, 2015, between and among Mylan Inc., as issuer, Mylan N.V., as parent, and The Bank of New York Mellon, as trustee, to the Indenture, dated November 29, 2013, filed by Mylan N.V. as Exhibit 4.5(b) to Form 10-Q for the quarter ended March 31, 2015, and incorporated herein by reference. | |||
Fourth Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and The Bank of New York Mellon, as trustee, to the Indenture dated November 29, 2013, by and between Mylan Inc. and The Bank of New York Mellon, as trustee, filed as Exhibit 4.7 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. | |||
Indenture, dated as of June 9, 2016, among Mylan N.V., as issuer, Mylan Inc., as guarantor, and The Bank of New York Mellon, as trustee, filed as Exhibit 4.1 to the Report on Form 8-K filed by Mylan N.V. with the SEC on June 15, 2016, and incorporated herein by reference. | |||
First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and The Bank of New York Mellon, as trustee, to the Indenture dated June 9, 2016, by and among Mylan N.V., Mylan Inc. and The Bank of New York Mellon, as trustee, filed as Exhibit 4.4 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. | |||
Indenture, dated November 22, 2016, among Mylan N.V., as issuer, Mylan Inc., as guarantor, and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, registrar and calculation agent, filed by Mylan N.V. as Exhibit 4.9 to Form 10-K for the fiscal year ended December 31, 2016, and incorporated herein by reference. | |||
First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, and registrar to the Indenture dated November 22, 2016, by and among Mylan N.V., Mylan Inc. and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, registrar and calculation agent, filed as Exhibit 4.5 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. | |||
Indenture, dated as of April 9, 2018, among Mylan Inc., as issuer, Mylan N.V., as guarantor, and The Bank of New York Mellon, as trustee, filed as Exhibit 4.1 to the Report on Form 8-K filed by Mylan N.V. with the SEC on April 9, 2018, and incorporated herein by reference. | |||
Exhibit No. | Description | ||
First Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V. and The Bank of New York Mellon, as trustee, to the Indenture dated April 9, 2018, by and among Mylan Inc., Mylan N.V. and The Bank of New York Mellon, as trustee, filed as Exhibit 4.8 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. | |||
Indenture, dated as of May 23, 2018, among Mylan Inc., as issuer, Mylan N.V., as guarantor and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent and registrar, filed as Exhibit 4.1 to the Report on Form 8-K filed by Mylan N.V. with the SEC on May 23, 2018, and incorporated herein by reference. | |||
First Supplemental Indenture dated November 16, 2020, by and among Mylan Inc., Utah Acquisition Sub Inc., Mylan II B.V., Viatris Inc. and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, and registrar, to the Indenture dated May 23, 2018, by and among Mylan Inc., Mylan N.V. and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, and registrar, filed as Exhibit 4.9 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference | |||
Indenture, dated as of June 22, 2020, between Upjohn Inc., as issuer, and The Bank of New York Mellon, as trustee, filed as Exhibit 4.1 to the Report on Form 8-K filed by Upjohn Inc. with the SEC on June 26, 2020, and incorporated herein by reference. | |||
First Supplemental Indenture dated November 16, 2020, by and among Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and The Bank of New York Mellon, as trustee, to the Indenture dated June 22, 2020, by and among Viatris Inc. and The Bank of New York Mellon, as trustee, filed as Exhibit 4.1 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. | |||
Indenture, dated as of June 23, 2020, among Upjohn Finance B.V., as issuer, Upjohn Inc., as guarantor, and Citibank, N.A., London Branch, as trustee, transfer agent, paying agent and registrar, filed as Exhibit 4.9 to the Report on Form 8-K filed by Upjohn Inc. with the SEC on June 26, 2020, and incorporated herein by reference. | |||
First Supplemental Indenture dated November 16, 2020, by and among Upjohn Finance B.V., Viatris Inc., Utah Acquisition Sub Inc., Mylan II B.V., Mylan Inc. and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, and registrar, to the Indenture dated June 23, 2020, by and among Upjohn Finance B.V., Viatris Inc. and Citibank, N.A., London Branch, as trustee, paying agent, transfer agent, and registrar, filed as Exhibit 4.2 to the Report on Form 8-K/A filed by Viatris Inc. with the SEC on November 19, 2020, and incorporated herein by reference. | |||
4.21* | Form of Viatris Inc. Debt Security. | ||
4.22* | Form of Certificate for Preferred Stock of Viatris Inc. | ||
4.23* | Form of Warrant Agreement. | ||
4.24* | Form of Warrant Certificate. | ||
4.25* | Form of Rights Agreement. | ||
Opinion of Cravath, Swaine & Moore LLP. | |||
5.2** | Opinion of NautaDutilh N.V. | ||
Exhibit No. | Description | ||
Opinion of Parker Poe Adams & Bernstein LLP. | |||
List of subsidiary guarantors and issuers of guaranteed securities, filed as Exhibit 22 to the Report on Form 10-K filed by Viatris Inc. with the SEC on February 27, 2025, and incorporated herein by reference. | |||
23.1** | Consent of Deloitte & Touche LLP, independent registered public accounting firm. | ||
Consent of Cravath, Swaine & Moore LLP (included as part of Exhibit 5.1). | |||
23.3** | Consent of NautaDutilh N.V. (included as part of Exhibit 5.2). | ||
Consent of Parker Poe Adams & Bernstein LLP (included as part of Exhibit 5.3). | |||
24.1** | Powers of Attorney (included in signature pages). | ||
Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of The Bank of New York Mellon, as trustee, with respect to the Form of Viatris Inc. Senior Indenture. | |||
Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of The Bank of New York Mellon, as trustee, with respect to the Form of Viatris Inc. Subordinated Indenture. | |||
Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of The Bank of New York Mellon, as trustee, with respect to the Form of Viatris Inc. Junior Subordinated Indenture. | |||
107.1** | Filing Fee Table. | ||
* | To be filed by amendment or incorporated by reference in connection with the offering of a particular class or series of securities. |
** | Filed herewith. |
Item 17. | Undertakings |
(a) | Each of the undersigned registrants hereby undertakes: |
(1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
(i) | To include any prospectus required by Section 10(a)(3) of the Securities Act; |
(ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and |
(iii) | To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; |
(2) | That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(3) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(4) | That, for the purpose of determining liability under the Securities Act to any purchaser: |
(i) | Each prospectus filed by the registrants pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and |
(ii) | Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. |
(5) | That, for the purpose of determining liability of the registrants under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrants undertake that in a primary offering of securities of the undersigned registrants pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrants will be sellers to the purchaser and will be considered to offer or sell such securities to such purchaser: |
(i) | Any preliminary prospectus or prospectus of the undersigned registrants relating to the offering required to be filed pursuant to Rule 424 under the Securities Act; |
(ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrants or used or referred to by the undersigned registrants; |
(iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrants or their securities provided by or on behalf of the undersigned registrants; and |
(iv) | Any other communication that is an offer in the offering made by the undersigned registrants to the purchaser. |
(6) | That, for purposes of determining any liability under the Securities Act, each filing of the registrants’ annual reports pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(7) | Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrants pursuant to the foregoing provisions, or otherwise, the registrants have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrants of expenses incurred or paid by a director, officer or controlling person of the registrants in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrants will, unless in the opinion of their counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. |
(8) | That, for purposes of determining any liability under the Securities Act: |
(i) | the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrants pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective; and |
(ii) | each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(9) | To file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”), in accordance with the rules and regulations prescribed by the SEC under Section 305(b)(2) of the Trust Indenture Act. |
VIATRIS INC. | ||||||
By: | /s/ Theodora Mistras | |||||
Name: Theodora Mistras | ||||||
Title: Chief Financial Officer | ||||||
Signature | Title | Date | ||||
/s/ Scott A. Smith | Chief Executive Officer and Director (Principal Executive Officer) | May 8, 2025 | ||||
Scott A. Smith | ||||||
/s/ Theodora Mistras | Chief Financial Officer (Principal Financial Officer) | May 8, 2025 | ||||
Theodora Mistras | ||||||
/s/ Paul Campbell | Chief Accounting Officer and Corporate Controller (Principal Accounting Officer) | May 8, 2025 | ||||
Paul Campbell | ||||||
/s/ Melina Higgins | Chair of the Board of Directors | May 8, 2025 | ||||
Melina Higgins | ||||||
/s/ W. Don Cornwell | Director | May 8, 2025 | ||||
W. Don Cornwell | ||||||
/s/ JoEllen Lyons Dillon | Director | May 8, 2025 | ||||
JoEllen Lyons Dillon | ||||||
/s/ Elisha Finney | Director | May 8, 2025 | ||||
Elisha Finney | ||||||
/s/ Leo Groothuis | Director | May 8, 2025 | ||||
Leo Groothuis | ||||||
Signature | Title | Date | ||||
/s/ James M. Kilts | Director | May 8, 2025 | ||||
James M. Kilts | ||||||
/s/ Harry A. Korman | Director | May 8, 2025 | ||||
Harry A. Korman | ||||||
/s/ Rajiv Malik | Director | May 8, 2025 | ||||
Rajiv Malik | ||||||
/s/ Richard A. Mark | Director | May 8, 2025 | ||||
Richard A. Mark | ||||||
/s/ Mark W. Parrish | Vice Chair and Director | May 8, 2025 | ||||
Mark W. Parrish | ||||||
/s/ Rogério V. Coelho | Director | May 8, 2025 | ||||
Rogério V. Coelho | ||||||
MYLAN INC. | ||||||
By: | /s/ John Miraglia | |||||
Name: John Miraglia | ||||||
Title: President and Treasurer | ||||||
Signature | Title | Date | ||||
/s/ John Miraglia | President, Treasurer and Director (Principal Executive Officer) | May 8, 2025 | ||||
John Miraglia | ||||||
/s/ Theodora Mistras | Chief Financial Officer (Principal Financial Officer) | May 8, 2025 | ||||
Theodora Mistras | ||||||
/s/ Paul Campbell | Chief Accounting Officer and Corporate Controller (Principal Accounting Officer) | May 8, 2025 | ||||
Paul Campbell | ||||||
/s/ Michael Rainerman | Director | May 8, 2025 | ||||
Michael Rainerman | ||||||
MYLAN II B.V. | ||||||
By: | /s/ John Miraglia | |||||
Name: John Miraglia | ||||||
Title: Director | ||||||
MYLAN II B.V. | ||||||
By: | /s/ John Miraglia | |||||
Name: John Miraglia | ||||||
Title: Director | ||||||
Signature | Title | Date | ||||
/s/ John Miraglia | Director | May 8, 2025 | ||||
John Miraglia | ||||||
/s/ Michael Rainerman | Director | May 8, 2025 | ||||
Michael Rainerman | ||||||
UTAH ACQUISITION SUB INC. | ||||||
By: | /s/ Michael Rainerman | |||||
Name: Michael Rainerman | ||||||
Title: President and Secretary | ||||||
Signature | Title | Date | ||||
/s/ Michael Rainerman | President, Secretary and Director (Principal Executive Officer) | May 8, 2025 | ||||
Michael Rainerman | ||||||
/s/ Howard Meyer | Treasurer, Vice President and Director (Principal Financial Officer and Principal Accounting Officer) | May 8, 2025 | ||||
Howard Meyer | ||||||
|
Trust Indenture Act Section
|
Indenture Section
|
||
|
310 (a) (1)
|
7.09
|
||
|
(a) (2)
|
7.09
|
||
|
(a) (3)
|
N.A.
|
||
|
(a) (4)
|
N.A.
|
||
|
(a) (5)
|
7.09
|
||
|
(b)
|
7.03; 7.09
|
||
|
311 (a)
|
7.11
|
||
|
(b)
|
7.11
|
||
|
312 (a)
|
2.07
|
||
|
(b)
|
12.05
|
||
|
(c)
|
12.05
|
||
|
313 (a)
|
7.10
|
||
|
(b) (1)
|
N.A.
|
||
|
(b) (2)
|
7.10
|
||
|
(c)
|
7.10
|
||
|
(d)
|
7.10
|
||
|
314 (a)
|
4.03; 12.02; 12.04
|
||
|
(b)
|
N.A.
|
||
|
(c) (1)
|
12.03
|
||
|
(c) (2)
|
12.03
|
||
|
(c) (3)
|
N.A.
|
||
|
(d)
|
N.A.
|
||
|
(e)
|
12.04
|
||
|
(f)
|
N.A.
|
||
|
315 (a)
|
7.01
|
||
|
(b)
|
7.05
|
||
|
(c)
|
7.01
|
||
|
(d)
|
7.01
|
||
|
(e)
|
6.11
|
||
|
(a) (1) (A)
|
6.05
|
||
|
(a) (1) (B)
|
6.04
|
||
|
(a) (2)
|
N.A.
|
||
|
316 (a) (last sentence)
|
2.11
|
||
|
(b)
|
6.07
|
||
|
(c)
|
8.03
|
||
|
317 (a) (1)
|
6.08
|
||
|
(a) (2)
|
6.09
|
||
|
(b)
|
2.06
|
||
|
318 (a)
|
12.01
|
| * |
This Cross Reference Table is not part of the Indenture.
|
|
ARTICLE I
|
|
|
DEFINITIONS AND INCORPORATION BY REFERENCE
|
|
|
Section 1.01. Definitions
|
1
|
|
Section 1.02. Other Definitions
|
9
|
|
Section 1.03. Rules of Construction
|
10
|
|
Section 1.04. Incorporation by Reference of Trust Indenture Act
|
10
|
|
ARTICLE II
|
|
|
THE SECURITIES
|
|
|
Section 2.01. Terms of the Securities
|
10
|
|
Section 2.02. Amount Unlimited; Issuable in Series
|
11
|
|
Section 2.03. Execution and Authentication
|
13
|
|
Section 2.04. Forms of Certificate of Authentication
|
14
|
|
Section 2.05. Registrar and Paying Agent
|
15
|
|
Section 2.06. Paying Agent To Hold Money in Trust
|
15
|
|
Section 2.07. Holder Lists
|
15
|
|
Section 2.08. Transfer and Exchange
|
16 |
|
Section 2.09. Replacement Securities
|
16
|
|
Section 2.10. Outstanding Securities
|
17
|
|
Section 2.11. Treasury Securities
|
17
|
|
Section 2.12. Temporary Securities
|
17
|
|
Section 2.13. Cancellation
|
18
|
|
Section 2.14. Defaulted Interest
|
18
|
|
Section 2.15. Identifying Number
|
18
|
|
Section 2.16. Deposit of Moneys
|
18
|
|
Section 2.17. Global Securities
|
18
|
|
Section 2.18. Issuance of Additional Securities
|
21
|
|
Section 2.19. Computation of Interest
|
22
|
|
Section 2.20. Currency of Payments in Respect of Securities
|
22
|
|
Section 2.21. Judgments
|
22
|
|
ARTICLE III
|
|
|
REDEMPTION AND PREPAYMENT
|
|
|
Section 3.01. Applicability of Right of Redemption
|
23 |
|
Section 3.02. Election To Redeem; Notices to Trustee
|
23 |
|
Section 3.03. Selection by Trustee of Securities To Be Redeemed
|
23
|
|
Section 3.04. Notice of Redemption
|
23
|
|
Section 3.05. Effect of Notice of Redemption
|
24
|
|
Section 3.06. Deposit of Redemption Price
|
24
|
|
Section 3.07. Securities Redeemed in Part
|
25 |
|
ARTICLE IV
|
|
|
COVENANTS
|
|
|
Section 4.01. Payment of Principal, Premium and Interest
|
25
|
|
Section 4.02. Maintenance of Office or Agency
|
25
|
|
Section 4.03. Reports to Holders
|
25
|
|
Section 4.04. Additional Guarantees
|
26
|
|
Section 4.05. Compliance Certificate
|
26
|
|
ARTICLE V
|
|
|
SUCCESSORS
|
|
|
Section 5.01. Consolidation, Merger and Sale of Assets
|
27 |
|
ARTICLE VI
|
|
|
DEFAULTS AND REMEDIES
|
|
|
Section 6.01. Events of Default
|
27
|
|
Section 6.02. Acceleration of Maturity; Rescission
|
29
|
|
Section 6.03. Other Remedies
|
30 |
|
Section 6.04. Waiver of Past Defaults and Events of Default
|
30
|
|
Section 6.05. Control by Majority
|
30
|
|
Section 6.06. Limitation on Suits
|
30
|
|
Section 6.07. Rights of Holders To Receive Payment
|
31 |
|
Section 6.08. Collection Suit by Trustee
|
31 |
|
Section 6.09. Trustee May File Proofs of Claim
|
31
|
|
Section 6.10. Priorities
|
31
|
|
Section 6.11. Undertaking for Costs
|
32 |
|
Section 6.12. Delay or Omission Not Waiver
|
32 |
|
ARTICLE VII
|
|
|
TRUSTEE
|
|
|
Section 7.01. Duties of Trustee
|
32
|
|
Section 7.02. Rights of Trustee
|
33
|
|
Section 7.03. Individual Rights of Trustee
|
34
|
|
Section 7.04. Trustee’s Disclaimer
|
34
|
|
Section 7.05. Notice of Defaults
|
35
|
|
Section 7.06. Compensation and Indemnity
|
35 |
|
Section 7.07. Replacement of Trustee
|
36
|
|
Section 7.08. Successor Trustee by Consolidation, Merger, etc.
|
36
|
|
Section 7.09. Eligibility; Disqualification
|
37
|
|
Section 7.10. Reports by Trustee to Holders
|
37
|
|
Section 7.11. Preferential Collection of Claims Against Company
|
37
|
|
Section 7.12. Appointment of Authenticating Agent
|
37
|
|
ARTICLE VIII
|
|
|
AMENDMENT, SUPPLEMENT AND WAIVER
|
|
|
Section 8.01. Without Consent of Holders
|
38
|
|
Section 8.02. With Consent of Holders
|
39
|
|
Section 8.03. Revocation and Effect of Consents
|
40
|
|
Section 8.04. Notation on or Exchange of Securities
|
40
|
|
Section 8.05. Trustee To Sign Amendments, etc.
|
40
|
|
Section 8.06. Compliance with Trust Indenture Act
|
41
|
|
Section 8.07. Effect of Execution of Supplemental Indenture
|
41
|
|
ARTICLE IX
|
|
|
SATISFACTION AND DISCHARGE OF INDENTURE; DEFEASANCE
|
|
|
Section 9.01. Applicability of Article
|
41
|
|
Section 9.02. Satisfaction and Discharge of Liability on Securities; Defeasance
|
41
|
|
Section 9.03. Conditions to Defeasance
|
42
|
|
Section 9.04. Deposited Money and U.S. Government Obligations To Be Held in Trust; Other Miscellaneous Provisions
|
43
|
|
Section 9.05. Reinstatement
|
44
|
|
Section 9.06. Moneys Held by Paying Agent
|
44
|
|
Section 9.07. Moneys Held by Trustee
|
44
|
|
Section 9.08. Deposits of Non-U.S. Currencies
|
44
|
|
ARTICLE X
|
|
|
GUARANTEES
|
|
|
Section 10.01. Guarantees
|
44
|
|
Section 10.02. Severability
|
46
|
|
Section 10.03. Limitation of Liability
|
46
|
|
Section 10.04. Contribution
|
46
|
|
Section 10.05. Subrogation
|
46
|
|
Section 10.06. Reinstatement
|
46
|
|
Section 10.07. Release of a Guarantor
|
46
|
|
Section 10.08. Benefits Acknowledged
|
47
|
|
ARTICLE XI
|
|
|
SINKING FUNDS
|
|
|
Section 11.01. Applicability of Sinking Fund
|
47
|
|
Section 11.02. Mandatory Sinking Fund Obligation
|
47
|
|
Section 11.03. Optional Redemption at Sinking Fund Redemption Price
|
47
|
|
Section 11.04. Application of Sinking Fund Payment
|
48
|
|
ARTICLE XII
|
|
|
MISCELLANEOUS
|
|
|
Section 12.01. Trust Indenture Act Controls
|
48
|
|
Section 12.02. Notices
|
48
|
|
Section 12.03. Certificate and Opinion as to Conditions Precedent
|
50
|
|
Section 12.04. Statements Required in Certificate and Opinion
|
50
|
|
Section 12.05. Communications by Holders with Other Holders
|
51
|
|
Section 12.06. Rules by Trustee and Agents
|
51
|
|
Section 12.07. No Personal Liability of Directors, Officers, Employees and Stockholders
|
51
|
|
Section 12.08. Governing Law; Waiver of Jury Trial; Jurisdiction
|
51
|
|
Section 12.09. No Adverse Interpretation of Other Agreements
|
52
|
|
Section 12.10. Successors
|
52
|
|
Section 12.11. Separability
|
52
|
|
Section 12.12. Counterpart Originals
|
52
|
|
Section 12.13. Table of Contents, Headings, etc.
|
52
|
|
Section 12.14. Benefits of Indenture
|
52
|
|
Section 12.15. Electronic Delivery
|
52
|
| Section 12.16. Office of Foreign Assets Control Sanctions Representations | 53 |
| Section 12.17. Foreign Account Tax Compliance Act (FACTA) | 53 |
| EXHIBIT A |
FORM OF NOTATION OF GUARANTEE |
|
Term
|
Defined
in
Section
|
|
|
“Agent Members”
|
2.17
|
|
|
“Authenticating Agent”
|
7.12
|
|
|
“Authorized Officers”
|
12.02
|
|
|
“Covenant Defeasance”
|
9.02
|
|
|
“Designated Currency”
|
2.21
|
|
|
“Event of Default”
|
6.01
|
|
|
“Exchange Rate”
|
6.01
|
|
|
“Instructions”
|
12.02
|
|
|
“Legal Defeasance”
|
9.02
|
|
|
“Mandatory Sinking Fund Payment”
|
11.01
|
|
|
“Optional Sinking Fund Payment”
|
11.01
|
|
|
“Paying Agent”
|
2.05
|
|
|
“Registrar”
|
2.05
|
|
|
“Successor Company”
|
5.01
|
| (1) |
that the form of such Securities has been established by a supplemental indenture or by or pursuant to a Company Order in accordance with Sections 2.01 and 2.02 and in conformity with the provisions of this Indenture;
|
| (2) |
that the terms of such Securities have been established in accordance with Sections 2.01 and 2.02 and in conformity with the other provisions of this Indenture; and
|
| (3) |
that such Securities, when authenticated and delivered by the Trustee and issued by the Company in the manner and subject to any conditions specified in such Opinion of Counsel, will constitute valid and legally binding obligations of
the Company, enforceable in accordance with their terms, subject to bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and other laws of general applicability relating to or affecting the enforcement of creditors’
rights from time to time in effect and to general equity principles, including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing, regardless of whether considered in a proceeding in equity or at law.
|
|
THE BANK OF NEW YORK MELLON,
as Trustee
|
||
| By: |
||
| Authorized Signatory | ||
|
THE BANK OF NEW YORK MELLON,
as Trustee
|
||
| By: |
[NAME OF AUTHENTICATING AGENT] | |
| as Authenticating Agent | ||
| By: | ||
| Authorized Signatory | ||
|
VIATRIS INC.
|
||
|
By:
|
||
|
Name:
|
||
| Title: | ||
|
THE GUARANTORS NAMED ON SCHEDULE A HERETO, as Guarantors,
|
||
|
By:
|
||
|
Name:
|
||
|
Title:
|
||
|
THE BANK OF NEW YORK MELLON,
as Trustee
|
||
|
By:
|
||
|
Name:
|
||
|
Title:
|
||
|
[GUARANTORS]
|
||
|
By:
|
||
|
Name:
|
||
|
Title:
|
||
|
Trust Indenture Act Section
|
Indenture Section
|
|||
|
310 (a) (1)
|
7.09
|
|||
|
(a) (2)
|
7.09
|
|||
|
(a) (3)
|
N.A.
|
|||
|
(a) (4)
|
N.A.
|
|||
|
(a) (5)
|
7.09
|
|||
|
(b)
|
7.03; 7.09
|
|||
|
311 (a)
|
7.11
|
|||
|
(b)
|
7.11
|
|||
|
312 (a)
|
2.07
|
|||
|
(b)
|
12.05
|
|||
|
(c)
|
12.05
|
|||
|
313 (a)
|
7.10
|
|||
|
(b) (1)
|
N.A.
|
|||
|
(b) (2)
|
7.10
|
|||
|
(c)
|
7.10
|
|||
|
(d)
|
7.10
|
|||
|
314 (a)
|
4.03; 12.02; 12.04
|
|||
|
(b)
|
N.A.
|
|||
|
(c) (1)
|
12.03
|
|||
|
(c) (2)
|
12.03
|
|||
|
(c) (3)
|
N.A.
|
|||
|
(d)
|
N.A.
|
|||
|
(e)
|
12.04
|
|||
|
(f)
|
N.A.
|
|||
|
315 (a)
|
7.01
|
|||
|
(b)
|
7.05
|
|||
|
(c)
|
7.01
|
|||
|
(d)
|
7.01
|
|||
|
(e)
|
6.11
|
|||
|
(a) (1) (A)
|
6.05
|
|||
|
(a) (1) (B)
|
6.04
|
|||
|
(a) (2)
|
N.A.
|
|||
|
316 (a) (last sentence)
|
2.11
|
|||
|
(b)
|
6.07
|
|||
|
(c)
|
8.03
|
|||
|
317 (a) (1)
|
6.08
|
|||
|
(a) (2)
|
6.09
|
|||
|
(b)
|
2.06
|
|||
|
318 (a)
|
12.01
|
|||
| * |
This Cross Reference Table is not part of the Indenture.
|
|
Page
|
||
|
ARTICLE I
|
||
|
DEFINITIONS AND INCORPORATION BY REFERENCE
|
||
|
Section 1.01.
|
Definitions
|
1
|
|
Section 1.02.
|
Other Definitions
|
9
|
|
Section 1.03.
|
Rules of Construction
|
10
|
|
Section 1.04.
|
Incorporation by Reference of Trust Indenture Act
|
11
|
|
ARTICLE II
|
||
|
THE SECURITIES
|
||
|
Section 2.01.
|
Terms of the Securities
|
11
|
|
Section 2.02.
|
Amount Unlimited; Issuable in Series
|
11
|
|
Section 2.03.
|
Execution and Authentication
|
13
|
|
Section 2.04.
|
Forms of Certificate of Authentication
|
14
|
|
Section 2.05.
|
Registrar and Paying Agent
|
15
|
|
Section 2.06.
|
Paying Agent To Hold Money in Trust
|
16
|
|
Section 2.07.
|
Holder Lists
|
16
|
|
Section 2.08.
|
Transfer and Exchange
|
16
|
|
Section 2.09.
|
Replacement Securities
|
17
|
|
Section 2.10.
|
Outstanding Securities
|
17
|
|
Section 2.11.
|
Treasury Securities
|
18
|
|
Section 2.12.
|
Temporary Securities
|
18
|
|
Section 2.13.
|
Cancellation
|
18
|
|
Section 2.14.
|
Defaulted Interest
|
18
|
|
Section 2.15.
|
Identifying Number
|
19 |
|
Section 2.16.
|
Deposit of Moneys
|
19
|
|
Section 2.17.
|
Global Securities
|
19
|
|
Section 2.18.
|
Issuance of Additional Securities
|
22
|
|
Section 2.19.
|
Computation of Interest
|
22
|
|
Section 2.20.
|
Currency of Payments in Respect of Securities
|
22
|
|
Section 2.21.
|
Judgments
|
23
|
|
ARTICLE III
|
||
|
REDEMPTION AND PREPAYMENT
|
||
|
Section 3.01.
|
Applicability of Right of Redemption
|
23
|
|
Section 3.02.
|
Election To Redeem; Notices to Trustee
|
23
|
|
Section 3.03.
|
Selection by Trustee of Securities To Be Redeemed
|
23
|
|
Section 3.04.
|
Notice of Redemption
|
24
|
|
Section 3.05.
|
Effect of Notice of Redemption
|
24
|
|
Section 3.06.
|
Deposit of Redemption Price
|
25
|
|
Section 3.07.
|
Securities Redeemed in Part
|
25
|
|
ARTICLE IV
|
||
|
COVENANTS
|
||
|
Section 4.01.
|
Payment of Principal, Premium and Interest
|
25
|
|
Section 4.02.
|
Maintenance of Office or Agency
|
25
|
|
Section 4.03.
|
Reports to Holders
|
26
|
|
Section 4.04.
|
Additional Guarantees
|
26
|
|
Section 4.05.
|
Compliance Certificate
|
27
|
|
ARTICLE V
|
||
|
SUCCESSORS
|
||
|
Section 5.01.
|
Consolidation, Merger and Sale of Assets
|
27
|
|
ARTICLE VI
|
||
|
DEFAULTS AND REMEDIES
|
||
|
Section 6.01.
|
Events of Default
|
27
|
|
Section 6.02.
|
Acceleration of Maturity; Rescission
|
29
|
|
Section 6.03.
|
Other Remedies
|
30
|
|
Section 6.04.
|
Waiver of Past Defaults and Events of Default
|
30
|
|
Section 6.05.
|
Control by Majority
|
30
|
|
Section 6.06.
|
Limitation on Suits
|
30
|
|
Section 6.07.
|
Rights of Holders To Receive Payment
|
31
|
|
Section 6.08.
|
Collection Suit by Trustee
|
31
|
|
Section 6.09.
|
Trustee May File Proofs of Claim
|
31
|
|
Section 6.10.
|
Priorities
|
32
|
|
Section 6.11.
|
Undertaking for Costs
|
32
|
|
Section 6.12.
|
Delay or Omission Not Waiver
|
32
|
|
ARTICLE VII
|
||
|
TRUSTEE
|
||
|
Section 7.01.
|
Duties of Trustee
|
32
|
|
Section 7.02.
|
Rights of Trustee
|
33
|
|
Section 7.03.
|
Individual Rights of Trustee
|
34
|
|
Section 7.04.
|
Trustee’s Disclaimer
|
35
|
|
Section 7.05.
|
Notice of Defaults
|
35
|
|
Section 7.06.
|
Compensation and Indemnity
|
35
|
|
Section 7.07.
|
Replacement of Trustee
|
36
|
|
Section 7.08.
|
Successor Trustee by Consolidation, Merger, etc.
|
37
|
|
Section 7.09.
|
Eligibility; Disqualification
|
37
|
|
Section 7.10.
|
Reports by Trustee to Holders
|
37
|
|
Section 7.11.
|
Preferential Collection of Claims Against Company
|
37
|
|
Section 7.12.
|
Appointment of Authenticating Agent
|
37
|
|
ARTICLE VIII
|
||
|
AMENDMENT, SUPPLEMENT AND WAIVER
|
||
|
Section 8.01.
|
Without Consent of Holders
|
38
|
|
Section 8.02.
|
With Consent of Holders
|
39
|
|
Section 8.03.
|
Revocation and Effect of Consents
|
40
|
|
Section 8.04.
|
Notation on or Exchange of Securities
|
41
|
|
Section 8.05.
|
Trustee To Sign Amendments, etc.
|
41
|
|
Section 8.06.
|
Compliance with Trust Indenture Act
|
41
|
|
Section 8.07.
|
Effect of Execution of Supplemental Indenture
|
41
|
|
Section 8.08.
|
Subordination Unimpaired
|
41
|
|
ARTICLE IX
|
||
|
SATISFACTION AND DISCHARGE OF INDENTURE; DEFEASANCE
|
||
|
Section 9.01.
|
Applicability of Article
|
41
|
|
Section 9.02.
|
Satisfaction and Discharge of Liability on Securities; Defeasance
|
41
|
|
Section 9.03.
|
Conditions to Defeasance
|
43
|
|
Section 9.04.
|
Deposited Money and U.S. Government Obligations To Be Held in Trust; Other Miscellaneous Provisions
|
44
|
|
Section 9.05.
|
Reinstatement
|
44
|
|
Section 9.06.
|
Moneys Held by Paying Agent
|
44
|
|
Section 9.07.
|
Moneys Held by Trustee
|
44
|
|
Section 9.08.
|
Deposits of Non-U.S. Currencies
|
45
|
|
ARTICLE X
|
||
|
GUARANTEES
|
||
|
Section 10.01.
|
Guarantees
|
45
|
|
Section 10.02.
|
Severability
|
46
|
|
Section 10.03.
|
Limitation of Liability
|
46
|
|
Section 10.04.
|
Contribution
|
47
|
|
Section 10.05.
|
Subrogation
|
47
|
|
Section 10.06.
|
Reinstatement
|
47
|
|
Section 10.07.
|
Release of a Guarantor
|
47
|
|
Section 10.08.
|
Benefits Acknowledged
|
47
|
|
Section 10.09.
|
Subordination of Guarantees
|
47
|
|
ARTICLE XI
|
||
|
SINKING FUNDS
|
||
|
Section 11.01.
|
Applicability of Sinking Fund
|
48
|
|
Section 11.02.
|
Mandatory Sinking Fund Obligation
|
48
|
|
Section 11.03.
|
Optional Redemption at Sinking Fund Redemption Price
|
48
|
|
Section 11.04.
|
Application of Sinking Fund Payment
|
49
|
|
ARTICLE XII
|
||
|
MISCELLANEOUS
|
||
|
Section 12.01.
|
Trust Indenture Act Controls
|
49
|
|
Section 12.02.
|
Notices
|
49
|
|
Section 12.03.
|
Certificate and Opinion as to Conditions Precedent
|
52
|
|
Section 12.04.
|
Statements Required in Certificate and Opinion
|
52
|
|
Section 12.05.
|
Communications by Holders with Other Holders
|
53
|
|
Section 12.06.
|
Rules by Trustee and Agents
|
53
|
|
Section 12.07.
|
No Personal Liability of Directors, Officers, Employees and Stockholders
|
53
|
|
Section 12.08.
|
Governing Law; Waiver of Jury Trial; Jurisdiction
|
53
|
|
Section 12.09.
|
No Adverse Interpretation of Other Agreements
|
54
|
|
Section 12.10.
|
Successors
|
54
|
|
Section 12.11.
|
Separability
|
54
|
|
Section 12.12.
|
Counterpart Originals
|
54
|
|
Section 12.13.
|
Table of Contents, Headings, etc.
|
54
|
|
Section 12.14.
|
Benefits of Indenture
|
54
|
|
Section 12.15.
|
Electronic Delivery
|
54
|
|
ARTICLE XIII
|
||
|
SUBORDINATION OF SECURITIES
|
||
|
Section 13.01.
|
Applicability of Article
|
55
|
|
Section 13.02.
|
Securities Subordinate to Senior Indebtedness
|
55
|
|
Section 13.03.
|
Payment Over of Proceeds Upon Dissolution, Etc.
|
55
|
|
Section 13.04.
|
No Payment When Senior Indebtedness of the Company in Default
|
56
|
|
Section 13.05.
|
Payment Permitted if No Default
|
56
|
|
Section 13.06.
|
Subrogation to Rights of Holders of Senior Indebtedness of the Company
|
56
|
|
Section 13.07.
|
Provisions Solely to Define Relative Rights
|
57
|
|
Section 13.08.
|
Trustee to Effectuate Subordination
|
57
|
|
Section 13.09.
|
No Waiver of Subordination Provisions
|
58
|
|
Section 13.10.
|
Notice to Trustee
|
58 |
|
Section 13.11.
|
Reliance on Judicial Order or Certificate of Liquidating Agent
|
58
|
|
Section 13.12.
|
Trustee Not Fiduciary for Holders of Senior Indebtedness of the Company
|
59
|
|
Section 13.13.
|
Rights of Trustee as Holder of Senior Indebtedness of the Company; Preservation of Trustee’s Rights
|
59
|
|
Section 13.14.
|
Article Applicable to Paying Agents
|
59 |
|
Section 13.15.
|
Defeasance of this Article XIII
|
59 |
|
EXHIBIT A
|
FORM OF NOTATION OF GUARANTEE
|
|
|
Term
|
Defined
in
Section
|
|
|
“Agent Members”
|
2.17
|
|
|
“Authenticating Agent”
|
7.12
|
|
|
“Authorized Officers”
|
12.02
|
|
|
“Covenant Defeasance”
|
9.02
|
|
|
“Designated Currency”
|
2.21
|
|
“Event of Default”
|
6.01
|
|
|
“Exchange Rate”
|
6.01
|
|
|
“Instructions”
|
12.02
|
|
|
“Legal Defeasance”
|
9.02
|
|
|
“Mandatory Sinking Fund Payment”
|
11.01
|
|
|
“Optional Sinking Fund Payment”
|
11.01
|
|
|
“Payment Blockage Period”
|
13.04
|
|
|
“Paying Agent”
|
2.05
|
|
|
“Proceeding”
|
13.03
|
|
|
“Registrar”
|
2.05
|
|
|
“Representative”
|
13.04
|
|
|
“Securities Payment”
|
13.03
|
|
|
“Successor Company”
|
5.01
|
| (1) |
that the form of such Securities has been established by a supplemental indenture or by or pursuant to a Company Order in accordance with Sections 2.01 and 2.02 and in conformity with the provisions of this Indenture;
|
| (2) |
that the terms of such Securities have been established in accordance with Sections 2.01 and 2.02 and in conformity with the other provisions of this Indenture; and
|
| (3) |
that such Securities, when authenticated and delivered by the Trustee and issued by the Company in the manner and subject to any conditions specified in such Opinion of Counsel, will constitute valid and legally binding obligations of the
Company, enforceable in accordance with their terms, subject to bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and other laws of general applicability relating to or affecting the enforcement of creditors’ rights from
time to time in effect and to general equity principles, including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing, regardless of whether considered in a proceeding in equity or at law.
|
|
THE BANK OF NEW YORK MELLON,
|
|||
|
as Trustee
|
|||
|
By:
|
|||
|
Authorized Signatory
|
|||
|
Dated:
|
|||
|
THE BANK OF NEW YORK MELLON,
|
|||
|
as Trustee
|
|||
|
By:
|
[NAME OF AUTHENTICATING AGENT]
|
||
|
as Authenticating Agent
|
|||
|
By:
|
|||
|
Authorized Signatory
|
|||
|
Dated:
|
|||
|
VIATRIS INC.
|
|||
|
By:
|
|||
|
Name:
|
|||
|
Title:
|
|||
|
THE GUARANTORS NAMED ON SCHEDULE A HERETO, as Guarantors,
|
|||
|
By:
|
|||
|
Name:
|
|||
|
Title:
|
|||
|
THE BANK OF NEW YORK MELLON, as Trustee
|
|||
|
By:
|
|||
|
Name:
|
|||
|
Title:
|
|||
|
[GUARANTORS]
|
||
|
By:
|
||
|
Name:
|
||
|
Title:
|
||
|
Indenture Section
|
||||
|
310 (a) (1)
|
7.09
|
|||
|
(a) (2)
|
7.09
|
|||
|
(a) (3)
|
N.A.
|
|||
|
(a) (4)
|
N.A.
|
|||
|
(a) (5)
|
7.09
|
|||
|
(b)
|
7.03; 7.09
|
|||
|
311 (a)
|
7.11
|
|||
|
(b)
|
7.11
|
|||
|
312 (a)
|
2.07
|
|||
|
(b)
|
12.05
|
|||
|
(c)
|
12.05
|
|||
|
313 (a)
|
7.10
|
|||
|
(b) (1)
|
N.A.
|
|||
|
(b) (2)
|
7.10
|
|||
|
(c)
|
7.10
|
|||
|
(d)
|
7.10
|
|||
|
314 (a)
|
4.03; 12.02; 12.04
|
|||
|
(b)
|
N.A.
|
|||
|
(c) (1)
|
12.03
|
|||
|
(c) (2)
|
12.03
|
|||
|
(c) (3)
|
N.A.
|
|||
|
(d)
|
N.A.
|
|||
|
(e)
|
12.04
|
|||
|
(f)
|
N.A.
|
|||
|
315 (a)
|
7.01
|
|||
|
(b)
|
7.05
|
|||
|
(c)
|
7.01
|
|||
|
(d)
|
7.01
|
|||
|
(e)
|
6.11
|
|||
|
(a) (1) (A)
|
6.05
|
|||
|
(a) (1) (B)
|
6.04
|
|||
|
(a) (2)
|
N.A.
|
|||
|
316 (a) (last sentence)
|
2.11
|
|||
|
(b)
|
6.07
|
|||
|
(c)
|
8.03
|
|||
|
317 (a) (1)
|
6.08
|
|||
|
(a) (2)
|
6.09
|
|||
|
(b)
|
2.06
|
|||
|
318 (a)
|
12.01
|
|||
| * |
This Cross Reference Table is not part of the Indenture.
|
| Page | ||
|
ARTICLE I
|
||
|
DEFINITIONS AND INCORPORATION BY REFERENCE
|
||
|
Section 1.01.
|
Definitions
|
1
|
|
Section 1.02.
|
Other Definitions
|
10
|
|
Section 1.03.
|
Rules of Construction
|
10
|
|
Section 1.04.
|
Incorporation by Reference of Trust Indenture Act
|
11
|
|
ARTICLE II
|
||
|
THE SECURITIES
|
||
|
Section 2.01.
|
Terms of the Securities
|
11
|
|
Section 2.02.
|
Amount Unlimited; Issuable in Series
|
11
|
|
Section 2.03.
|
Execution and Authentication
|
13
|
|
Section 2.04.
|
Forms of Certificate of Authentication
|
15
|
|
Section 2.05.
|
Registrar and Paying Agent
|
15
|
|
Section 2.06.
|
Paying Agent To Hold Money in Trust
|
16
|
|
Section 2.07.
|
Holder Lists
|
16
|
|
Section 2.08.
|
Transfer and Exchange
|
16
|
|
Section 2.09.
|
Replacement Securities
|
17
|
|
Section 2.10.
|
Outstanding Securities
|
17
|
|
Section 2.11.
|
Treasury Securities
|
18
|
|
Section 2.12.
|
Temporary Securities
|
18
|
|
Section 2.13.
|
Cancellation
|
18
|
|
Section 2.14.
|
Defaulted Interest
|
18
|
|
Section 2.15.
|
Identifying Number
|
19
|
|
Section 2.16.
|
Deposit of Moneys
|
19
|
|
Section 2.17.
|
Global Securities
|
19
|
|
Section 2.18.
|
Issuance of Additional Securities
|
22
|
|
Section 2.19.
|
Computation of Interest
|
22
|
|
Section 2.20.
|
Currency of Payments in Respect of Securities
|
22
|
|
Section 2.21.
|
Judgments
|
23
|
|
ARTICLE III
|
||
|
REDEMPTION AND PREPAYMENT
|
||
|
Section 3.01.
|
Applicability of Right of Redemption
|
23
|
|
Section 3.02.
|
Election To Redeem; Notices to Trustee
|
23
|
|
Section 3.03.
|
Selection by Trustee of Securities To Be Redeemed
|
23
|
|
Section 3.04.
|
Notice of Redemption
|
24
|
|
Section 3.05.
|
Effect of Notice of Redemption
|
25
|
|
Section 3.06.
|
Deposit of Redemption Price
|
25
|
|
Section 3.07.
|
Securities Redeemed in Part
|
25
|
|
ARTICLE IV
|
||
|
COVENANTS
|
||
|
Section 4.01.
|
Payment of Principal, Premium and Interest
|
25
|
|
Section 4.02.
|
Maintenance of Office or Agency
|
26
|
|
Section 4.03.
|
Reports to Holders
|
26
|
|
Section 4.04.
|
Additional Guarantees
|
26
|
|
Section 4.05.
|
Compliance Certificate
|
27
|
|
ARTICLE V
|
||
|
SUCCESSORS
|
||
|
Section 5.01.
|
Consolidation, Merger and Sale of Assets
|
27
|
|
ARTICLE VI
|
||
|
DEFAULTS AND REMEDIES
|
||
|
Section 6.01.
|
Events of Default
|
28
|
|
Section 6.02.
|
Acceleration of Maturity; Rescission
|
29
|
|
Section 6.03.
|
Other Remedies
|
30
|
|
Section 6.04.
|
Waiver of Past Defaults and Events of Default
|
30
|
|
Section 6.05.
|
Control by Majority
|
30
|
|
Section 6.06.
|
Limitation on Suits
|
31
|
|
Section 6.07.
|
Rights of Holders To Receive Payment
|
31
|
|
Section 6.08.
|
Collection Suit by Trustee
|
31
|
|
Section 6.09.
|
Trustee May File Proofs of Claim
|
31
|
|
Section 6.10.
|
Priorities
|
32
|
|
Section 6.11.
|
Undertaking for Costs
|
32
|
|
Section 6.12.
|
Delay or Omission Not Waiver
|
32
|
|
ARTICLE VII
|
||
|
TRUSTEE
|
||
|
Section 7.01.
|
Duties of Trustee
|
32
|
|
Section 7.02.
|
Rights of Trustee
|
33
|
|
Section 7.03.
|
Individual Rights of Trustee
|
34
|
|
Section 7.04.
|
Trustee’s Disclaimer
|
35
|
|
Section 7.05.
|
Notice of Defaults
|
35
|
|
Section 7.06.
|
Compensation and Indemnity
|
35
|
|
Section 7.07.
|
Replacement of Trustee
|
36
|
|
Section 7.08.
|
Successor Trustee by Consolidation, Merger, etc.
|
37
|
|
Section 7.09.
|
Eligibility; Disqualification
|
37
|
|
Section 7.10.
|
Reports by Trustee to Holders
|
37
|
|
Section 7.11.
|
Preferential Collection of Claims Against Company
|
37
|
|
Section 7.12.
|
Appointment of Authenticating Agent
|
37
|
|
ARTICLE VIII
|
||
|
AMENDMENT, SUPPLEMENT AND WAIVER
|
||
|
Section 8.01.
|
Without Consent of Holders
|
38
|
|
Section 8.02.
|
With Consent of Holders
|
39
|
|
Section 8.03.
|
Revocation and Effect of Consents
|
40
|
|
Section 8.04.
|
Notation on or Exchange of Securities
|
41
|
|
Section 8.05.
|
Trustee To Sign Amendments, etc.
|
41
|
|
Section 8.06.
|
Compliance with Trust Indenture Act
|
41
|
|
Section 8.07.
|
Effect of Execution of Supplemental Indenture
|
41
|
|
Section 8.08.
|
Subordination Unimpaired
|
41
|
|
ARTICLE IX
|
||
|
SATISFACTION AND DISCHARGE OF INDENTURE; DEFEASANCE
|
||
|
Section 9.01.
|
Applicability of Article
|
41
|
|
Section 9.02.
|
Satisfaction and Discharge of Liability on Securities; Defeasance
|
41
|
|
Section 9.03.
|
Conditions to Defeasance
|
43
|
|
Section 9.04.
|
Deposited Money and U.S. Government Obligations To Be Held in Trust; Other Miscellaneous Provisions
|
44
|
|
Section 9.05.
|
Reinstatement
|
44
|
|
Section 9.06.
|
Moneys Held by Paying Agent
|
44
|
|
Section 9.07.
|
Moneys Held by Trustee
|
44
|
|
Section 9.08.
|
Deposits of Non-U.S. Currencies
|
45
|
|
ARTICLE X
|
||
|
GUARANTEES
|
||
|
Section 10.01.
|
Guarantees
|
45
|
|
Section 10.02.
|
Severability
|
46
|
|
Section 10.03.
|
Limitation of Liability
|
46
|
|
Section 10.04.
|
Contribution
|
47
|
|
Section 10.05.
|
Subrogation
|
47
|
|
Section 10.06.
|
Reinstatement
|
47
|
|
Section 10.07.
|
Release of a Guarantor
|
47
|
|
Section 10.08.
|
Benefits Acknowledged
|
47
|
|
Section 10.09.
|
Subordination of Guarantees
|
47
|
|
ARTICLE XI
|
||
|
SINKING FUNDS
|
||
|
Section 11.01.
|
Applicability of Sinking Fund
|
48
|
|
Section 11.02.
|
Mandatory Sinking Fund Obligation
|
48
|
|
Section 11.03.
|
Optional Redemption at Sinking Fund Redemption Price
|
48
|
|
Section 11.04.
|
Application of Sinking Fund Payment
|
48
|
|
ARTICLE XII
|
||
|
MISCELLANEOUS
|
||
|
Section 12.01.
|
Trust Indenture Act Controls
|
49
|
|
Section 12.02.
|
Notices
|
49
|
|
Section 12.03.
|
Certificate and Opinion as to Conditions Precedent
|
51
|
|
Section 12.04.
|
Statements Required in Certificate and Opinion
|
51
|
|
Section 12.05.
|
Communications by Holders with Other Holders
|
52
|
|
Section 12.06.
|
Rules by Trustee and Agents
|
52
|
|
Section 12.07.
|
No Personal Liability of Directors, Officers, Employees and Stockholders
|
52
|
|
Section 12.08.
|
Governing Law; Waiver of Jury Trial; Jurisdiction
|
52
|
|
Section 12.09.
|
No Adverse Interpretation of Other Agreements
|
53
|
|
Section 12.10.
|
Successors
|
53
|
|
Section 12.11.
|
Separability
|
53
|
|
Section 12.12.
|
Counterpart Originals
|
53
|
|
Section 12.13.
|
Table of Contents, Headings, etc.
|
53
|
|
Section 12.14.
|
Benefits of Indenture
|
53
|
|
Section 12.15.
|
Electronic Delivery
|
53
|
|
ARTICLE XIII
|
||
|
SUBORDINATION OF SECURITIES
|
||
|
Section 13.01.
|
Applicability of Article
|
54
|
|
Section 13.02.
|
Securities Subordinate to Senior Indebtedness and Subordinated Indebtedness
|
54
|
|
Section 13.03.
|
Payment Over of Proceeds Upon Dissolution, Etc.
|
54
|
|
Section 13.04.
|
No Payment When Senior Indebtedness or Subordinated Indebtedness of the Company in Default
|
55
|
|
Section 13.05.
|
Payment Permitted if No Default
|
56
|
|
Section 13.06.
|
Subrogation to Rights of Holders of Senior Indebtedness and Subordinated Indebtedness of the Company
|
56
|
|
Section 13.07.
|
Provisions Solely to Define Relative Rights
|
56
|
|
Section 13.08.
|
Trustee to Effectuate Subordination
|
56
|
|
Section 13.09.
|
No Waiver of Subordination Provisions
|
56
|
|
Section 13.10.
|
Notice to Trustee
|
57
|
|
Section 13.11.
|
Reliance on Judicial Order or Certificate of Liquidating Agent
|
57
|
|
Section 13.12.
|
Trustee Not Fiduciary for Holders of Senior Indebtedness or Subordinated Indebtedness of the Company
|
58
|
|
Section 13.13.
|
Rights of Trustee as Holder of Senior Indebtedness or Subordinated Indebtedness of the Company; Preservation of Trustee’s Rights
|
58
|
|
Section 13.14.
|
Article Applicable to Paying Agents
|
58
|
|
Section 13.15.
|
Defeasance of this Article XIII
|
58
|
|
EXHIBIT A
|
FORM OF NOTATION OF GUARANTEE
|
|
|
Term
|
Defined
in
Section
|
|
|
“Agent Members”
|
2.17
|
|
|
“Authenticating Agent”
|
7.12
|
|
|
“Authorized Officers”
|
12.02
|
|
|
“Covenant Defeasance”
|
9.02
|
|
|
“Designated Currency”
|
2.21
|
|
|
“Event of Default”
|
6.01
|
|
|
“Exchange Rate”
|
6.01
|
|
|
“Instructions”
|
12.02
|
|
|
“Legal Defeasance”
|
9.02
|
|
|
“Mandatory Sinking Fund Payment”
|
11.01
|
|
|
“Optional Sinking Fund Payment”
|
11.01
|
|
|
“Payment Blockage Period”
|
13.04
|
|
|
“Paying Agent”
|
2.05
|
|
|
“Proceeding”
|
13.03
|
|
|
“Registrar”
|
2.05
|
|
|
“Representative”
|
13.04
|
|
|
“Securities Payment”
|
13.03
|
|
|
“Successor Company”
|
5.01
|
| (1) |
that the form of such Securities has been established by a supplemental indenture or by or pursuant to a Company Order in accordance with Sections 2.01 and 2.02 and in conformity with the provisions of this Indenture;
|
| (2) |
that the terms of such Securities have been established in accordance with Sections 2.01 and 2.02 and in conformity with the other provisions of this Indenture; and
|
| (3) |
that such Securities, when authenticated and delivered by the Trustee and issued by the Company in the manner and subject to any conditions specified in such Opinion of Counsel, will constitute valid and legally binding obligations of
the Company, enforceable in accordance with their terms, subject to bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and other laws of general applicability relating to or affecting the enforcement of creditors’
rights from time to time in effect and to general equity principles, including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing, regardless of whether considered in a proceeding in equity or at law.
|
|
THE BANK OF NEW YORK MELLON,
|
||
|
as Trustee
|
||
|
By:
|
||
|
Authorized Signatory
|
||
|
THE BANK OF NEW YORK MELLON,
|
||
|
as Trustee
|
||
|
By:
|
[NAME OF AUTHENTICATING AGENT]
|
|
|
as Authenticating Agent
|
||
|
By:
|
||
|
Authorized Signatory
|
||
|
VIATRIS INC.
|
||
|
By:
|
||
|
Name:
|
||
| Title: | ||
|
THE GUARANTORS NAMED ON SCHEDULE A HERETO, as Guarantors,
|
||
|
By:
|
||
|
Name:
|
||
| Title: | ||
|
THE BANK OF NEW YORK MELLON,
as Trustee
|
||
|
By:
|
||
|
Name:
|
||
| Title: | ||
| [GUARANTORS] | ||
| By: |
||
| Name: | ||
| Title: | ||
![]() |

| 1. |
With respect to the Senior Debt Securities, Subordinated Debt Securities and Junior Subordinated Debt Securities and any Guarantees thereof to be issued under the Senior Indenture, the Subordinated Indenture and the Junior Subordinated
Indenture, respectively, when (A) the Senior Trustee, Subordinated Trustee and Junior Subordinated Trustee, respectively, is qualified to act as trustee under the Senior Indenture, the Subordinated Indenture and the Junior Subordinated
Indenture, respectively, (B) the Senior Trustee, Subordinated Trustee and Junior Subordinated Trustee, respectively, has duly executed and delivered the Senior Indenture, the Subordinated Indenture and the Junior Subordinated Indenture,
respectively, and any supplemental indenture thereunder, (C) the Senior Indenture, the Subordinated Indenture and the Junior Subordinated Indenture, respectively, and any supplemental indenture thereunder has been duly authorized and
validly executed and delivered by Viatris Inc. and any Guarantor to the Senior Trustee, Subordinated Trustee and Junior Subordinated Trustee, respectively, (D) the Senior Indenture, the Subordinated Indenture, and the Junior Subordinated
Indenture, respectively, has been duly qualified under the Trust Indenture Act of 1939, as amended, (E) the boards of directors of Viatris Inc. and any Guarantor, a duly constituted and acting committee thereof or any officers of Viatris
Inc. and such Guarantor delegated such authority (such board of directors, committee or officers being hereinafter referred to as the “Boards”) have taken all necessary corporate or other organizational action, as applicable, to
approve the issuance and terms of a particular series of Senior Debt Securities, Subordinated Debt Securities and Junior Subordinated Debt Securities, respectively, and Guarantees, if any, the terms of the offering thereof and related
matters, and (F) such Senior Debt Securities, Subordinated Debt Securities and Junior Subordinated Debt Securities, respectively, and Guarantees, if any, have been duly executed, authenticated, issued and delivered in accordance with the
provisions of the Senior Indenture, the Subordinated Indenture and the Junior Subordinated Indenture, respectively, including any supplemental indenture related thereto, and the applicable definitive purchase, underwriting or similar
agreement approved by the applicable Boards upon payment of the consideration therefor provided for therein, such Senior Debt Securities, Subordinated Debt Securities and Junior Subordinated Debt Securities, respectively, and such
Guarantees thereof will be validly issued and will constitute valid and binding obligations of Viatris Inc. and each such Guarantor, enforceable against them in accordance with their terms (subject to applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent transfer and other similar laws affecting creditors’ rights generally from time to time in effect and to general principles of equity, including, without limitation, concepts of materiality,
reasonableness, good faith and fair dealing, regardless of whether considered in a proceeding in equity or at law).
|
| 2. |
With respect to shares of Common Stock, when both (a) the Board of Viatris Inc. has taken all necessary corporate action to approve the issuance of and the terms of the offering of (i) the Debt Securities or Preferred Stock, as the case
may be, convertible or exchangeable into Common Stock and (ii) the shares of Common Stock and (b) certificates representing the shares of Common Stock have been duly executed, countersigned, registered and delivered either (i) in accordance
with the applicable definitive purchase, underwriting or similar agreement approved by the Board of Viatris Inc. upon payment of the consideration therefor (which per share consideration is not less than the par value of the Common Stock)
provided for therein or (ii) upon conversion or exercise of such Debt Security or Preferred Stock, as the case may be, in accordance with the terms of such Security or the instrument governing such Security providing for such conversion or
exercise as approved by the Board of Viatris Inc., for the consideration approved by the Board of Viatris Inc. (which per share consideration is not less than the par value of the Common Stock), then such shares of Common Stock will be
validly issued, fully paid and nonassessable.
|
| 3. |
With respect to shares of Preferred Stock, when (a) the Board of Viatris Inc. has taken all necessary corporate action to approve the issuance and terms of a particular series of Preferred Stock, the terms of the offering thereof and
related matters, including the adoption of a Certificate of Designation relating to such Preferred Stock (a “Certificate”) and the filing of such Certificate with the Secretary of State of the State of Delaware, (b) such Certificate
has been properly filed with the Secretary of State of the State of Delaware and (c) certificates representing such shares of Preferred Stock have been duly executed, countersigned, registered and delivered either (i) in accordance with the
applicable definitive purchase, underwriting or similar agreement approved by the Board of Viatris Inc. upon payment of the consideration therefor (which per share consideration is not less than the par value of the Preferred Stock)
provided for therein or (ii) upon conversion or exercise of any other Security, in accordance with the terms of such Security or the instrument governing such Security providing for such conversion or exercise as approved by the Board of
Viatris Inc., for the consideration approved by the Board of Viatris Inc. (which per share consideration is not less than the par value of the Preferred Stock), then such shares of Preferred Stock will be validly issued, fully paid and
nonassessable.
|
| 4. |
With respect to the Warrants, when (a) the Warrant Agent has duly executed and delivered the Warrant Agreement, (b) the Warrant Agreement has been duly authorized and validly executed and delivered by Viatris Inc. to the Warrant Agent,
(c) the Board of Viatris Inc. has taken all necessary corporate action to approve the due and valid issuance and terms of a particular series of Warrants, the terms of the offering thereof and related matters and (d) such Warrants have been
duly executed, countersigned, registered and delivered in accordance with the provisions of the Warrant Agreement and the applicable definitive purchase, underwriting or similar agreement approved by the Board of Viatris Inc., upon payment
of the consideration therefor provided for therein, such Warrants will constitute valid and binding obligations of Viatris Inc., enforceable against Viatris Inc. in accordance with their terms (subject to applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent transfer and other similar laws affecting creditors’ rights generally from time to time in effect and to general principles of equity, including, without limitation, concepts of materiality,
reasonableness, good faith and fair dealing, regardless of whether considered in a proceeding in equity or at law).
|
| 5. |
With respect to the Rights, when (a) the Rights Agent has duly executed and delivered the Rights Agreement, (b) the Rights Agreement has been duly authorized and validly executed and delivered by Viatris Inc. to the Rights Agent, (c) the
Board of Viatris Inc. has taken all necessary corporate action to approve the due and valid issuance and terms of a particular series of Rights, the terms of the offering thereof and related matters and (d) such Rights have been duly
executed and delivered in accordance with the provisions of the Rights Agreement and the applicable definitive purchase, underwriting or similar agreement approved by the Board of Viatris Inc., upon payment of the consideration therefor
provided for therein, such Rights will constitute valid and binding obligations of Viatris Inc., enforceable against Viatris Inc. in accordance with their terms (subject to applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent transfer and other similar laws affecting creditors’ rights generally from time to time in effect and to general principles of equity, including, without limitation, concepts of materiality, reasonableness, good faith and fair
dealing, regardless of whether considered in a proceeding in equity or at law).
|
| 6. |
With respect to the Units, when (a) the Unit Agent has duly executed and delivered the Unit Agreement, (b) the Unit Agreement has been duly authorized and validly executed and delivered by Viatris Inc. to the Unit Agent, (c) the Board of
Viatris Inc. has taken all necessary corporate action to approve the due and valid issuance and terms of a particular series of Units, the terms of the offering thereof and related matters and (d) such Units have been duly executed and
delivered in accordance with the provisions of the Unit Agreement and the applicable definitive purchase, underwriting or similar agreement approved by the Board of Viatris Inc., upon payment of the consideration therefor provided for
therein, such Units will constitute valid and binding obligations of Viatris Inc., enforceable against Viatris Inc. in accordance with their terms (subject to applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
transfer and other similar laws affecting creditors’ rights generally from time to time in effect and to general principles of equity, including, without limitation, concepts of materiality, reasonableness, good faith and fair dealing,
regardless of whether considered in a proceeding in equity or at law).
|
|
Very truly yours,
|
|
|
/s/ Cravath, Swaine & Moore LLP
|
|
Viatris Inc.
|
|
1000 Mylan Boulevard
|
|
Canonsburg, PA 15317
|
![]() |
|
Beethovenstraat 400
1082 PR Amsterdam
T +31 20 71 71 000
|
Amsterdam, 8 May 2025
|
|
Amsterdam
|
This communication is confidential and may be subject to professional privilege. All legal relationships are subject to NautaDutilh N.V.'s general terms and conditions (see https://www.nautadutilh.com/terms), which apply
mutatis mutandis to our relationship with third parties relying on statements of NautaDutilh N.V., include a limitation of liability clause, have been filed with the Rotterdam District Court and will be provided free of charge upon
request. NautaDutilh N.V.; corporate seat Rotterdam; trade register no. 24338323.
|
|
Brussels
|
|
|
London
|
|
|
Luxemburg
|
|
|
New York
|
|
|
Rotterdam
|
![]() |
||
| 2 | ||
| a. |
drafts of documents reviewed by us will be signed in the form of those drafts, each copy of a document conforms to the original, each original is authentic, and each signature is the genuine signature of the individual purported to have
placed that signature;
|
| b. |
if any signature under any document is an electronic signature (as opposed to a handwritten (“wet ink”) signature) only, it is either a qualified electronic signature within the meaning of the eIDAS Regulation, or the method used for
signing is otherwise sufficiently reliable;
|
| c. |
the Registration Statement, in the form reviewed by us, has become or will become effective automatically upon filing with the SEC by Viatris Inc.;
|
![]() |
||
| 3 | ||
| d. |
the Current Articles are the Articles of Association currently in force (as supported by the Extract) and as they will be in force at each Relevant Moment;
|
| e. |
the Dutch Company has not (i) been dissolved (ontbonden), (ii) ceased to exist pursuant to a merger (fusie) or a division (splitsing), (iii) been converted (omgezet) into another legal form, either national or foreign, (iv) had its assets placed under administration (onder
bewind gesteld), (v) been declared bankrupt (failliet verklaard), been granted a suspension of payments (surseance van betaling verleend), or started
or become subject to statutory proceedings for the restructuring of its debts (akkoordprocedure) or (vi) been made subject to similar proceedings in any jurisdiction or otherwise been limited in its
power to dispose of its assets. The Extract and our inquiries of today with the Insolvency Registers support the items (i) through (v) (except for any statutory proceedings for the restructuring of debts (akkoordprocedure)
that have not, or not yet, been filed in the Insolvency Registers) of this assumption. However, this information does not constitute conclusive evidence that the events set out in items (i) through (v) have not occurred;
|
| f. |
each Power of Attorney (i) is in full force and effect, and (ii) under any applicable law other than Dutch law, validly authorises the person or persons purported to be granted power of attorney, to represent and bind the Dutch Company
for the purposes stated therein;
|
| g. |
under any applicable law, the Agreements shall constitute the legal, valid and binding obligations of the parties expressed to be a party thereto, enforceable against them in accordance with their terms; and
|
| h. |
at each Relevant Moment, each of the assumptions made in this opinion letter will be correct in all aspects by reference to the facts and circumstances then existing.
|
| 1. |
The Dutch Company has been duly incorporated and is validly existing as a besloten vennootschap met beperkte aansprakelijkheid.
|
![]() |
||
| 4 | ||
| 2. |
Any Agreement when duly signed by all members of the Board, any member of the Board or a holder of a Power of Attorney for such purpose, shall have been duly and validly executed on behalf of the Dutch Company.
|
| 3. |
The Registration Statement has been validly signed on behalf of the Dutch Company.
|
| 4. |
The Dutch Company has the corporate power to enter into any Agreements and to perform its obligations thereunder and to sign the Registration Statement.
|
| 5. |
The Dutch Company has taken all corporate action required by its Articles of Association and Dutch law in connection with the entering into any Agreements and the performance of its obligations thereunder and with the signing of the
Registration Statement.
|
| A. |
The opinion expressed in paragraph 1 (Incorporation and Corporate Status) of this opinion letter must not be read to imply that the Dutch Company cannot be dissolved
(ontbonden). A company such as the Dutch Company may be dissolved, inter alia by the competent court at the request of the company's management board, any
interested party (belanghebbende) or the public prosecution office in certain circumstances, such as when there are certain defects in the incorporation of the company. Any such dissolution will not
have retro-active effect.
|
| B. |
The Extract does not constitute conclusive evidence of the facts reflected therein.
|
| C. |
Pursuant to Article 2:7 DCC, any transaction entered into by a legal entity may be nullified by the legal entity itself or its liquidator in bankruptcy proceedings (curator) if the objects of that
entity were transgressed by the transaction and the other party to the transaction knew or should have known this without independent investigation (wist of zonder eigen onderzoek moest weten). The
Dutch Supreme Court (Hoge Raad der Nederlanden) has ruled that in determining whether the objects of a legal entity are transgressed, not only the description of the objects in that legal entity's
articles of association (statuten) is decisive, but all (relevant) circumstances must be taken into account, in particular whether the interests of the legal entity were served by the transaction.
Based on the objects clause contained in the Current Articles, we have no reason to believe that, by entering into any Agreements or by the performance of its obligations thereunder, the Dutch Company would transgress the description of the
objects contained in its Current Articles. However, we cannot assess whether there are other relevant circumstances that must be taken into account, in particular whether the interests of the Dutch Company are served by entering into any
Agreements since this is a matter of fact.
|
![]() |
||
| 5 | ||
| D. |
A power of attorney or mandate granted by the Dutch Company will terminate in the event of a bankruptcy and become ineffective upon the suspension of payments of the principal or, unless otherwise provided, the attorney.
|
| E. |
The opinions expressed in this opinion letter may be limited or affected by:
|
| a. |
rules relating to Insolvency Proceedings or similar proceedings under a foreign law and other rules affecting creditors' rights generally;
|
| b. |
the provisions of fraudulent preference and fraudulent conveyance (Actio Pauliana) and similar rights available in other jurisdictions to insolvency practitioners and insolvency office holders in
bankruptcy proceedings or creditors;
|
| c. |
claims based on tort (onrechtmatige daad);
|
| d. |
sanctions and measures, including but not limited to those concerning export control, pursuant to European Union regulations, under the Dutch Sanctions Act 1977 (Sanctiewet 1977) or other
legislation;
|
| e. |
the Anti-Boycott Regulation and related legislation;
|
| f. |
any intervention, recovery or resolution measure by any regulatory or other authority or governmental body in relation to financial enterprises or their affiliated entities; and
|
| g. |
the rules of force majeure (niet toerekenbare tekortkoming), reasonableness and fairness (redelijkheid en billijkheid), suspension (opschorting), dissolution (ontbinding), unforeseen circumstances (onvoorziene omstandigheden) and vitiated consent (i.e.,
duress (bedreiging), fraud (bedrog), abuse of circumstances (misbruik van omstandigheden) and error (dwaling)) or a difference of intention (wil) and declaration (verklaring).
|
| F. |
This opinion letter does not purport to express any opinion or view on the operational rules and procedures of any clearing or settlement system or agency.
|
![]() |
||
| 6 | ||
![]() |
||
| 7 | ||
![]() |
||
| 8 | ||
|
"Agreements"
|
any Indenture or any Notation of Guarantee
|
|
"Anti-Boycott Regulation"
|
Regulation (EC) No 2271/96 on protecting against the effects of the extra-territorial application of legislation adopted by a third country, and actions based thereon or resulting therefrom
|
|
"Articles of Association"
|
the Dutch Company’s articles of association (statuten) as they read from time to time
|
|
"Board"
|
the board of directors (bestuur) of the Dutch Company.
|
|
"Commercial Register"
|
the Commercial Register held by the Dutch Chamber of Commerce (handelsregister gehouden door de Kamer van Koophandel)
|
|
"Common Stock"
|
shares of common stock in Viatris Inc. with a par value of $0.01 per share
|
|
"Corporate Documents"
|
the Deed of Incorporation, the Current Articles and the Extract
|
|
"Current Articles"
|
the Articles of Association as contained in the Deed of Incorporation
|
|
"DCC"
|
the Dutch Civil Code (Burgerlijk Wetboek)
|
|
"Debt Securities"
|
one or more series of debt securities issuable by Viatris Inc. and applicable guarantees offered by, among others, the Dutch Company and registered pursuant to the Registration Statement.
|
|
"Deed of Incorporation"
|
the deed of incorporation (akte van oprichting) of the Dutch Company, dated 25 July 2019
|
![]() |
||
| 9 | ||
|
"Dutch Bankruptcy Code"
|
the Dutch Bankruptcy Code (Faillissementswet)
|
|
"Dutch Company"
|
Mylan II B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid), registered with the Commercial Register under number
75453444
|
|
"eIDAS Regulation"
|
Regulation (EU) No 910/2014 of the European Parliament and of the Council of 23 July 2014 on electronic identification and trust services for electronic transactions in the internal market and repealing
Directive 1999/93/EC
|
|
"Extract"
|
a pdf copy of an extract from the Commercial Register, received by us by email and dated the date of this opinion letter with respect to the Dutch Company
|
|
"Forms of Indenture"
|
the forms of indenture as attached to the Registration Statement as Exhibit 4.11, Exhibit 4.12 and Exhibit 4.13
|
|
"Form of Notation of
Guarantee"
|
the form of notation of guarantee as attached to each Form of Indenture as Exhibit A
|
|
"Indenture"
|
any indenture or supplemental indenture to be entered into between Viatris Inc., the Company as Guarantor, any additional Guarantors and the Trustee (as defined therein) in respect of the issuance of Debt
Securities, in the form of any Form of Indenture
|
|
"Insolvency Proceedings"
|
any insolvency proceedings within the meaning of Regulation (EU) 2015/848 on insolvency proceedings (recast), listed in Annex A thereto and any statutory proceedings for the restructuring of debts (akkoordprocedure) pursuant to the Dutch Bankruptcy Code
|
![]() |
||
| 10 | ||
|
"Insolvency Registers"
|
the online central insolvency register (Centraal Insolventie Register), the online EU Insolvency Register (Centraal Insolventie
Register - EU Registraties) and the online Register of Decisions in a WHOA Procedure (Register uitspraken in een WHOA-procedure) held by the Council for the Administration of Justice (Raad voor de Rechtspraak)
|
|
"NautaDutilh"
|
NautaDutilh N.V.
|
|
"the Netherlands"
|
the European territory of the Kingdom of the Netherlands and "Dutch" is in or from the Netherlands
|
|
"Notation of Guarantee"
|
any notation of guarantee in the form of the Form of Notation of Guarantee
|
|
"Power of Attorney"
|
any power of attorney granted or to be granted by the Dutch Company for the purposes of executing Agreements on behalf of the Dutch Company and the performance of the Dutch Company’s obligations thereunder
and under the Registered Securities, as relevant
|
|
"Preferred Stock"
|
shares of preferred stock in Viatris Inc. with a par value of $0.01 per share
|
|
"Registered Securities"
|
the Debt Securities, Common Stock, Preferred Stock, Warrants, Rights and Units
|
|
"Registration Statement"
|
Viatris Inc.’s registration statement on Form S-3 filed or to be filed with the SEC in the form reviewed by us
|
|
"Relevant Moment"
|
each time when the Dutch Company as Guarantor enters into an Indenture and/or a Notation of Guarantee
|
![]() |
||
| 11 | ||
|
"Rights"
|
one or more series of rights issuable by Viatris Inc. and registered pursuant to the Registration Statement consisting of one more rights to purchase Debt Securities, Common Stock or Preferred Stock
|
|
"SEC"
|
the United States Securities and Exchange Commission
|
|
"Units"
|
one or more series of units issuable by Viatris Inc. and registered pursuant to the Registration Statement consisting of two or more constituent securities in the form of Debt Securities, Common Stock,
Preferred Stock, Rights or Warrants or any combination of such securities as specified in the applicable prospectus supplement
|
|
"Viatris Inc."
|
Viatris Inc., a Delaware corporation with its address at 1000 Mylan Boulevard, Canonsburg, Pennsylvania 15317
|
|
"Warrants"
|
one or more series of warrants issuable by Viatris Inc. and registered pursuant to the Registration Statement for the purchase of Debt Securities, Common Stock or Preferred Stock as specified in the
applicable prospectus supplement
|
|
Atlanta, GA
Charleston, SC
Charlotte, NC
Columbia, SC
Greenville, SC
Raleigh, NC
Spartanburg, SC
Washington, D.C. |
|
Viatris Inc.
Mylan Inc.
1000 Mylan Boulevard
Canonsburg, Pennsylvania 15317
|
|
May 8, 2025
|
|
Page 2
|
|
May 8, 2025
|
|
Page 3
|
|
New York
(Jurisdiction of incorporation
if not a U.S. national bank)
|
13-5160382
(I.R.S. employer
identification no.)
|
|
240 Greenwich Street, New York, N.Y.
(Address of principal executive offices)
|
10286
(Zip code)
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
83-4364296
(I.R.S. employer
identification no.)
|
|
1000 Mylan Boulevard
Canonsburg, Pennsylvania
(Address of principal executive offices)
|
15317
(Zip code)
|
|
Pennsylvania
(State or other jurisdiction of
incorporation or organization)
|
25-1211621
(I.R.S. employer
identification no.)
|
|
1000 Mylan Boulevard
Canonsburg, Pennsylvania
(Address of principal executive offices)
|
15317
(Zip code)
|
|
The Netherlands
(State or other jurisdiction of
incorporation or organization)
|
None
(I.R.S. employer
identification no.)
|
|
Krijgsman 20
1186 DM Amstelveen
Amsterdam
The Netherlands
(Address of principal executive offices)
|
(Zip code)
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
84-4554869
(I.R.S. employer
identification no.)
|
|
1000 Mylan Boulevard
Canonsburg, Pennsylvania
(Address of principal executive offices)
|
15317
(Zip code)
|
| 1. |
General information. Furnish the following information as to the Trustee:
|
| (a) |
Name and address of each examining or supervising authority to which it is subject.
|
|
Name
|
Address
|
|
Superintendent of the Department of
Financial Services of the State of New York
|
One State Street, New York, N.Y.
10004-1417, and Albany, N.Y. 12223
|
|
Federal Reserve Bank of New York
|
33 Liberty Street, New York, N.Y. 10045
|
|
Federal Deposit Insurance Corporation
|
550 17th Street, NW
Washington, D.C. 20429
|
|
The Clearing House Association L.L.C.
|
100 Broad Street
New York, N.Y. 10004
|
| (b) |
Whether it is authorized to exercise corporate trust powers.
|
| 2. |
Affiliations with Obligor.
|
| 16. |
List of Exhibits.
|
| 1. |
A copy of the Organization Certificate of The Bank of New York Mellon (formerly known as The Bank of New York, itself formerly Irving Trust Company) as now in effect, which contains the authority to commence business and a grant of
powers to exercise corporate trust powers. (Exhibit 1 to Amendment No. 1 to Form T-1 filed with Registration Statement No. 33-6215, Exhibits 1a and 1b to Form T-1 filed with Registration Statement No. 33-21672, Exhibit 1 to Form T-1 filed
with Registration Statement No. 33-29637, Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121195 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152735).
|
| 4. |
A copy of the existing By-laws of the Trustee (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-261533).
|
| 6. |
The consent of the Trustee required by Section 321(b) of the Act (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-229519).
|
| 7. |
A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority.
|
|
THE BANK OF NEW YORK MELLON
|
|||
|
By:
|
/s/ Nathaniel Henkle
|
||
|
Name:
|
Nathaniel Henkle
|
||
|
Title:
|
Agent
|
||
|
ASSETS
|
Dollar amounts in thousands
|
||
|
Cash and balances due from depository institutions:
|
|||
|
Noninterest-bearing balances and currency and coin.................................................................
|
3,316,000
|
||
|
Interest-bearing balances............................................................................................................
|
96,711,000
|
||
|
Securities:
|
|||
|
Held-to-maturity securities.........................................................................................................
|
48,596,000
|
||
|
Available-for-sale debt securities................................................................................................
|
87,787,000
|
||
|
Equity securities with readily determinable fair values not held for trading..............................
|
0
|
||
|
Federal funds sold and securities purchased under agreements to resell:
|
|||
|
Federal funds sold in domestic offices........................................................................................
|
0
|
||
|
Securities purchased under agreements to resell.........................................................................
|
24,014,000
|
||
|
Loans and lease financing receivables:
|
|||
|
Loans and leases held for sale.....................................................................................................
|
0
|
||
|
Loans and leases held for investment..........................................................................................
|
37,084,000
|
||
|
LESS: Allowance for credit losses on loans and leases..............................................................
|
272,000
|
||
|
Loans and leases held for investment, net of allowance..............................................................
|
36,812,000
|
||
|
Trading assets..................................................................................................................................
|
7,593,000
|
||
|
Premises and fixed assets (including right-of-use assets)...............................................................
|
2,912,000
|
||
|
Other real estate owned...................................................................................................................
|
0
|
||
|
Investments in unconsolidated subsidiaries and associated companies..........................................
|
2,021,000
|
||
|
Direct and indirect investments in real estate ventures...................................................................
|
0 |
||
|
Intangible assets..............................................................................................................................
|
7,329,000
|
||
|
Other assets.....................................................................................................................................
|
18,864,000
|
||
|
Total assets......................................................................................................................................
|
335,955,000
|
||
|
LIABILITIES
|
|||
|
Deposits:
|
|||
|
In domestic offices......................................................................................................................
|
194,168,000
|
||
|
Noninterest-bearing.....................................................................................................................
|
61,444,000
|
||
|
Interest-bearing...........................................................................................................................
|
132,724,000
|
||
|
In foreign offices, Edge and Agreement subsidiaries, and IBFs.................................................
|
97,210,000
|
||
|
Noninterest-bearing.....................................................................................................................
|
3,557,000
|
||
|
Interest-bearing............................................................................................................................
|
93,653,000
|
||
|
Federal funds purchased and securities sold under agreements to repurchase:
|
|||
|
Federal funds purchased in domestic offices................................................................................
|
0 |
||
|
Securities sold under agreements to repurchase...........................................................................
|
2,499,000
|
||
|
Trading liabilities.............................................................................................................................
|
2,911,000
|
||
|
Other borrowed money:
|
3,031,000
|
||
|
(includes mortgage indebtedness)................................................................................................
|
|||
|
Not applicable
|
|||
|
Not applicable
|
|||
|
Subordinated notes and debentures.................................................................................................
|
0 |
||
|
Other liabilities................................................................................................................................
|
8,176,000
|
||
|
Total liabilities.................................................................................................................................
|
307,995,000
|
||
|
EQUITY CAPITAL
|
|||
|
Perpetual preferred stock and related surplus..................................................................................
|
0
|
||
|
Common stock.................................................................................................................................
|
1,135,000
|
||
|
Surplus (exclude all surplus related to preferred stock)..................................................................
|
12,511,000
|
||
|
Retained earnings............................................................................................................................
|
17,415,000
|
||
|
Accumulated other comprehensive income....................................................................................
|
-3,101,000
|
||
|
Other equity capital components.....................................................................................................
|
0
|
||
|
Total bank equity capital.................................................................................................................
|
27,960,000
|
||
|
Noncontrolling (minority) interests in consolidated subsidiaries...................................................
|
0 |
||
|
Total equity capital..........................................................................................................................
|
27,960,000
|
||
|
Total liabilities and equity capital....................................................................................................
|
335,955,000
|
|
Robin A. Vince
Jeffrey A. Goldstein
Joseph J. Echevarria
|
|
Directors
|
|
New York
(Jurisdiction of incorporation
if not a U.S. national bank)
|
13-5160382
(I.R.S. employer
identification no.)
|
|
240 Greenwich Street, New York, N.Y.
(Address of principal executive offices)
|
10286
(Zip code)
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
83-4364296
(I.R.S. employer
identification no.)
|
|
1000 Mylan Boulevard
Canonsburg, Pennsylvania
(Address of principal executive offices)
|
15317
(Zip code)
|
|
Pennsylvania
(State or other jurisdiction of
incorporation or organization)
|
25-1211621
(I.R.S. employer
identification no.)
|
|
1000 Mylan Boulevard
Canonsburg, Pennsylvania
(Address of principal executive offices)
|
15317
(Zip code)
|
|
The Netherlands
(State or other jurisdiction of
incorporation or organization)
|
None
(I.R.S. employer
identification no.)
|
|
Krijgsman 20
1186 DM Amstelveen
Amsterdam
The Netherlands
(Address of principal executive offices)
|
(Zip code)
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
84-4554869
(I.R.S. employer
identification no.)
|
|
1000 Mylan Boulevard
Canonsburg, Pennsylvania
(Address of principal executive offices)
|
15317
(Zip code)
|
| 1. |
General information. Furnish the following information as to the Trustee:
|
|
(a)
|
Name and address of each examining or supervising authority to which it is subject.
|
|
Name
|
Address
|
|
Superintendent of the Department of
Financial Services of the State of New York
|
One State Street, New York, N.Y.
10004-1417, and Albany, N.Y. 12223
|
|
Federal Reserve Bank of New York
|
33 Liberty Street, New York, N.Y. 10045
|
|
Federal Deposit Insurance Corporation
|
550 17th Street, NW
Washington, D.C. 20429
|
|
The Clearing House Association L.L.C.
|
100 Broad Street
New York, N.Y. 10004
|
| (b) |
Whether it is authorized to exercise corporate trust powers.
|
| 2. |
Affiliations with Obligor.
|
| 16. |
List of Exhibits.
|
| 1. |
A copy of the Organization Certificate of The Bank of New York Mellon (formerly known as The Bank of New York, itself formerly Irving Trust Company) as now in effect, which contains the authority to commence business and a grant of powers
to exercise corporate trust powers. (Exhibit 1 to Amendment No. 1 to Form T-1 filed with Registration Statement No. 33-6215, Exhibits 1a and 1b to Form T-1 filed with Registration Statement No. 33-21672, Exhibit 1 to Form T-1 filed with
Registration Statement No. 33-29637, Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121195 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152735).
|
| 4. |
A copy of the existing By-laws of the Trustee (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-261533).
|
| 6. |
The consent of the Trustee required by Section 321(b) of the Act (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-229519).
|
| 7. |
A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority.
|
|
THE BANK OF NEW YORK MELLON
|
|||
|
By:
|
/s/ Nathaniel Henkle
|
||
|
Name:
|
Nathaniel Henkle
|
||
|
Title:
|
Agent
|
||
|
ASSETS
|
Dollar amounts in thousands
|
||
|
Cash and balances due from depository institutions:
|
|||
|
Noninterest-bearing balances and currency and coin.................................................................
|
3,316,000
|
||
|
Interest-bearing balances............................................................................................................
|
96,711,000
|
||
|
Securities:
|
|||
|
Held-to-maturity securities.........................................................................................................
|
48,596,000
|
||
|
Available-for-sale debt securities................................................................................................
|
87,787,000
|
||
|
Equity securities with readily determinable fair values not held for trading..............................
|
0
|
||
|
Federal funds sold and securities purchased under agreements to resell:
|
|||
|
Federal funds sold in domestic offices........................................................................................
|
0
|
||
|
Securities purchased under agreements to resell.........................................................................
|
24,014,000
|
||
|
Loans and lease financing receivables:
|
|||
|
Loans and leases held for sale.....................................................................................................
|
0
|
||
|
Loans and leases held for investment..........................................................................................
|
37,084,000
|
||
|
LESS: Allowance for credit losses on loans and leases..............................................................
|
272,000
|
||
|
Loans and leases held for investment, net of allowance..............................................................
|
36,812,000
|
||
|
Trading assets..................................................................................................................................
|
7,593,000
|
||
|
Premises and fixed assets (including right-of-use assets)...............................................................
|
2,912,000
|
||
|
Other real estate owned...................................................................................................................
|
0
|
||
|
Investments in unconsolidated subsidiaries and associated companies..........................................
|
2,021,000
|
||
|
Direct and indirect investments in real estate ventures...................................................................
|
0 |
||
|
Intangible assets..............................................................................................................................
|
7,329,000
|
||
|
Other assets.....................................................................................................................................
|
18,864,000
|
||
|
Total assets......................................................................................................................................
|
335,955,000
|
||
|
LIABILITIES
|
|||
|
Deposits:
|
|||
|
In domestic offices......................................................................................................................
|
194,168,000
|
||
|
Noninterest-bearing.....................................................................................................................
|
61,444,000
|
||
|
Interest-bearing...........................................................................................................................
|
132,724,000
|
||
|
In foreign offices, Edge and Agreement subsidiaries, and IBFs.................................................
|
97,210,000
|
||
|
Noninterest-bearing.....................................................................................................................
|
3,557,000
|
||
|
Interest-bearing............................................................................................................................
|
93,653,000
|
||
|
Federal funds purchased and securities sold under agreements to repurchase:
|
|||
|
Federal funds purchased in domestic offices................................................................................
|
0 |
||
|
Securities sold under agreements to repurchase...........................................................................
|
2,499,000
|
||
|
Trading liabilities.............................................................................................................................
|
2,911,000
|
||
|
Other borrowed money:
|
3,031,000
|
||
|
(includes mortgage indebtedness)................................................................................................
|
|||
|
Not applicable
|
|||
|
Not applicable
|
|||
|
Subordinated notes and debentures.................................................................................................
|
0 |
||
|
Other liabilities................................................................................................................................
|
8,176,000
|
||
|
Total liabilities.................................................................................................................................
|
307,995,000
|
||
|
EQUITY CAPITAL
|
|||
|
Perpetual preferred stock and related surplus..................................................................................
|
0
|
||
|
Common stock.................................................................................................................................
|
1,135,000
|
||
|
Surplus (exclude all surplus related to preferred stock)..................................................................
|
12,511,000
|
||
|
Retained earnings............................................................................................................................
|
17,415,000
|
||
|
Accumulated other comprehensive income....................................................................................
|
-3,101,000
|
||
|
Other equity capital components.....................................................................................................
|
0
|
||
|
Total bank equity capital.................................................................................................................
|
27,960,000
|
||
|
Noncontrolling (minority) interests in consolidated subsidiaries...................................................
|
0 |
||
|
Total equity capital..........................................................................................................................
|
27,960,000
|
||
|
Total liabilities and equity capital....................................................................................................
|
335,955,000
|
|
Robin A. Vince
Jeffrey A. Goldstein
Joseph J. Echevarria
|
|
Directors
|
|
New York
(Jurisdiction of incorporation
if not a U.S. national bank)
|
13-5160382
(I.R.S. employer
identification no.)
|
|
240 Greenwich Street, New York, N.Y.
(Address of principal executive offices)
|
10286
(Zip code)
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
83-4364296
(I.R.S. employer
identification no.)
|
|
1000 Mylan Boulevard
Canonsburg, Pennsylvania
(Address of principal executive offices)
|
15317
(Zip code)
|
|
Pennsylvania
(State or other jurisdiction of
incorporation or organization)
|
25-1211621
(I.R.S. employer
identification no.)
|
|
1000 Mylan Boulevard
Canonsburg, Pennsylvania
(Address of principal executive offices)
|
15317 (Zip code)
|
|
The Netherlands
(State or other jurisdiction of
incorporation or organization)
|
None
(I.R.S. employer
identification no.)
|
|
Krijgsman 20
1186 DM Amstelveen
Amsterdam
The Netherlands
(Address of principal executive offices)
|
(Zip code)
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
84-4554869
(I.R.S. employer
identification no.)
|
|
1000 Mylan Boulevard
Canonsburg, Pennsylvania
(Address of principal executive offices)
|
15317
(Zip code)
|
| 1. |
General information. Furnish the following information as to the Trustee:
|
|
(a)
|
Name and address of each examining or supervising authority to which it is subject.
|
|
Name
|
Address
|
|
Superintendent of the Department of
Financial Services of the State of New York
|
One State Street, New York, N.Y.
10004-1417, and Albany, N.Y. 12223
|
|
Federal Reserve Bank of New York
|
33 Liberty Street, New York, N.Y. 10045
|
|
Federal Deposit Insurance Corporation
|
550 17th Street, NW
Washington, D.C. 20429
|
|
The Clearing House Association L.L.C.
|
100 Broad Street
New York, N.Y. 10004
|
| (b) |
Whether it is authorized to exercise corporate trust powers.
|
| 2. |
Affiliations with Obligor.
|
| 16. |
List of Exhibits.
|
| 1. |
A copy of the Organization Certificate of The Bank of New York Mellon (formerly known as The Bank of New York, itself formerly Irving Trust Company) as now in effect, which contains the authority to commence business and a grant of powers
to exercise corporate trust powers. (Exhibit 1 to Amendment No. 1 to Form T-1 filed with Registration Statement No. 33-6215, Exhibits 1a and 1b to Form T-1 filed with Registration Statement No. 33-21672, Exhibit 1 to Form T-1 filed with
Registration Statement No. 33-29637, Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121195 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152735).
|
| 4. |
A copy of the existing By-laws of the Trustee (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-261533).
|
| 6. |
The consent of the Trustee required by Section 321(b) of the Act (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-229519).
|
| 7. |
A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority.
|
|
THE BANK OF NEW YORK MELLON
|
|||
|
By:
|
/s/ Nathaniel Henkle
|
||
|
Name:
|
Nathaniel Henkle
|
||
|
Title:
|
Agent
|
||
|
ASSETS
|
Dollar amounts in thousands
|
||
|
Cash and balances due from depository institutions:
|
|||
|
Noninterest-bearing balances and currency and coin.................................................................
|
3,316,000
|
||
|
Interest-bearing balances............................................................................................................
|
96,711,000
|
||
|
Securities:
|
|||
|
Held-to-maturity securities.........................................................................................................
|
48,596,000
|
||
|
Available-for-sale debt securities................................................................................................
|
87,787,000
|
||
|
Equity securities with readily determinable fair values not held for trading..............................
|
0
|
||
|
Federal funds sold and securities purchased under agreements to resell:
|
|||
|
Federal funds sold in domestic offices........................................................................................
|
0
|
||
|
Securities purchased under agreements to resell.........................................................................
|
24,014,000
|
||
|
Loans and lease financing receivables:
|
|||
|
Loans and leases held for sale.....................................................................................................
|
0
|
||
|
Loans and leases held for investment..........................................................................................
|
37,084,000
|
||
|
LESS: Allowance for credit losses on loans and leases..............................................................
|
272,000
|
||
|
Loans and leases held for investment, net of allowance..............................................................
|
36,812,000
|
||
|
Trading assets..................................................................................................................................
|
7,593,000
|
||
|
Premises and fixed assets (including right-of-use assets)...............................................................
|
2,912,000
|
||
|
Other real estate owned...................................................................................................................
|
0
|
||
|
Investments in unconsolidated subsidiaries and associated companies..........................................
|
2,021,000
|
||
|
Direct and indirect investments in real estate ventures...................................................................
|
0 |
||
|
Intangible assets..............................................................................................................................
|
7,329,000
|
||
|
Other assets.....................................................................................................................................
|
18,864,000
|
||
|
Total assets......................................................................................................................................
|
335,955,000
|
||
|
LIABILITIES
|
|||
|
Deposits:
|
|||
|
In domestic offices......................................................................................................................
|
194,168,000
|
||
|
Noninterest-bearing.....................................................................................................................
|
61,444,000
|
||
|
Interest-bearing...........................................................................................................................
|
132,724,000
|
||
|
In foreign offices, Edge and Agreement subsidiaries, and IBFs.................................................
|
97,210,000
|
||
|
Noninterest-bearing.....................................................................................................................
|
3,557,000
|
||
|
Interest-bearing............................................................................................................................
|
93,653,000
|
||
|
Federal funds purchased and securities sold under agreements to repurchase:
|
|||
|
Federal funds purchased in domestic offices................................................................................
|
0 |
||
|
Securities sold under agreements to repurchase...........................................................................
|
2,499,000
|
||
|
Trading liabilities.............................................................................................................................
|
2,911,000
|
||
|
Other borrowed money:
|
3,031,000
|
||
|
(includes mortgage indebtedness)................................................................................................
|
|||
|
Not applicable
|
|||
|
Not applicable
|
|||
|
Subordinated notes and debentures.................................................................................................
|
0 |
||
|
Other liabilities................................................................................................................................
|
8,176,000
|
||
|
Total liabilities.................................................................................................................................
|
307,995,000
|
||
|
EQUITY CAPITAL
|
|||
|
Perpetual preferred stock and related surplus..................................................................................
|
0
|
||
|
Common stock.................................................................................................................................
|
1,135,000
|
||
|
Surplus (exclude all surplus related to preferred stock)..................................................................
|
12,511,000
|
||
|
Retained earnings............................................................................................................................
|
17,415,000
|
||
|
Accumulated other comprehensive income....................................................................................
|
-3,101,000
|
||
|
Other equity capital components.....................................................................................................
|
0
|
||
|
Total bank equity capital.................................................................................................................
|
27,960,000
|
||
|
Noncontrolling (minority) interests in consolidated subsidiaries...................................................
|
0 |
||
|
Total equity capital..........................................................................................................................
|
27,960,000
|
||
|
Total liabilities and equity capital....................................................................................................
|
335,955,000
|
|
Robin A. Vince
Jeffrey A. Goldstein
Joseph J. Echevarria
|
|
Directors
|
| | Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward |
| Newly Registered Securities | ||||||||||||
| | | | Rule 456(b) and | (3) | (3) | (3) | (2) | (2) | | | | |
| | | Rule 456(b) and | (3) | (3) | (3) | (2) | (2) | | | | | |
| | | Rule 456(b) and | (3) | (3) | (3) | (2) | (2) | | | | | |
| | | Rule 456(b) and | (3) | (3) | (3) | (2) | (2) | | | | | |
| | | Rule 456(b) and | (3) | (3) | (3) | (2) | (2) | | | | | |
| | | Rule 456(b) and | (3) | (3) | (3) | (2) | (2) | | | | | |
| | | Rule 456(b) and | (3) | (3) | (3) | (2) | (2) | | | | | |
| Fees Previously Paid | N/A | N/A | N/A | N/A | N/A | N/A | | N/A | | | | |
| Carry Forward Securities | ||||||||||||
| Carry Forward Securities | N/A | N/A | N/A | N/A | | N/A | | | N/A | N/A | N/A | N/A |
| | Total Offering Amounts | | | | | | | | | |||
| | Total Fees Previously Paid | | | | | | | | | |||
| | Total Fee Offsets | | | | | | | | | |||
| | Net Fee Due | | | | | | | | | |||